Search the table below to find a reporting guideline that is appropriate for your research. You can search reporting guidelines under development here.
Reporting guidelines are recommendations to help write up research clearly.
Your research will be used by people from different disciplines and backgrounds for decades to come. Reporting guidelines are community-created recommendations for describing what you did and what you found so that everyone can understand, repeat, apply, and synthesise your work. Although they recommend information to include in your manuscript, they don’t dictate how to order that information.
Most reporting guidelines consist of the full guidance (sometimes called an Explanation and Elaboration document) and a checklist. The full guidance provides detailed explanations and examples for each item, and the checklist allows you to demonstrate adherence to editors.
You can use reporting guidelines throughout your research process. However you use reporting guidelines, please cite them.
Writing manuscripts
Write confidently using a reporting guideline to quickly turn a blank page into a thorough and impactful manuscript.
Checking
Use a reporting checklist to demonstrate to an editor or peer reviewer that you have included everything. Many journals require completed checklists at submission.
Writing applications
Reporting guidelines can help you write funding applications, ethics applications, and protocols, but they won’t make design decisions for you!
Reporting guidelines are neither design nor quality appraisal tools.
Although reporting guidelines recommend information to include when writing up research, they do not mandate how to design research. Similarly, when reviewing literature, although you can use reporting guidelines to assess whether a manuscript is well reported, you cannot use them to appraise whether that study is well designed.
| Acronym | Title | Study type | Clinical area | Section of report |
|---|---|---|---|---|
| RIGHT | A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement | Clinical practice guidelines | No clinical specialty specified | Whole report |
| CONSORT | CONSORT 2025 Statement: updated guideline for reporting randomised trials | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| CHEERS 2022 | Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations | Economic evaluations | No clinical specialty specified | Whole report |
| ENTREQ | Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ | Qualitative research, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Narrative sections (discussion etc.), Procedure/Method |
| PRISMA-P | Preferred Reporting Items for Systematic Review and Meta -Analysis Protocols (PRISMA-P) 2015 statement | Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Protocol-whole report |
| SPIRIT | SPIRIT 2025 Statement: Defining standard protocol items for clinical trials | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Protocol-whole report |
| SQUIRE 2.0 | SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process | Quality improvement studies | No clinical specialty specified | Whole report |
| STARD 2015 | STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies | Clinical trials, Diagnostic and prognostic studies, Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| SRQR | Standards for reporting qualitative research: a synthesis of recommendations | Qualitative research | No clinical specialty specified | Whole report |
| TIDieR-Placebo | TIDieR-Placebo : a guide and checklist for reporting placebo and sham controls | Clinical trials, Experimental studies, Observational studies, Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Intervention (exposure) |
| AGREE Reporting Guideline Checklist | The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines | Clinical practice guidelines | No clinical specialty specified | Whole report |
| ARRIVE | The ARRIVE Guidelines 2.0: updated guidelines for reporting animal research | Animal pre-clinical research | No clinical specialty specified | Whole report |
| CARE | The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development | Observational studies | No clinical specialty specified | Whole report |
| PRISMA 2020 | The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| STROBE | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies | Observational studies | No clinical specialty specified | Whole report |
| RIGHT-Ad@pt | A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist | Clinical practice guidelines | No clinical specialty specified | Whole report |
| PRISMA-CI | AHRQ Series on Complex Intervention Systematic Reviews – Paper 6: PRISMA-CI Extension Statement & Checklist | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| RIGHT for INT | An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT | Clinical practice guidelines | No clinical specialty specified | Whole report |
| SAMPL | Basic Statistical Reporting for Articles Published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or The SAMPL Guidelines | No study design specified | No clinical specialty specified | Statistical methods and analyses |
| TIDieR | Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide | Clinical trials, Experimental studies, Observational studies, Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Intervention (exposure) |
| BRISQ | Biospecimen reporting for improved study quality (BRISQ) | No study design specified | No clinical specialty specified | Biospecimen/bioresource information |
| CHEERS-VOI | CHEERS Value of Information (CHEERS-VOI) Reporting Standards – Explanation and Elaboration | Economic evaluations | No clinical specialty specified | Whole report |
| ROSES-I | CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement | Observational studies | Infectious diseases | Whole report |
| CONSORT 2010 statement: extension checklist for reporting within person randomised trials | Clinical trials, Experimental studies | No clinical specialty specified | Whole report | |
| CONSORT 2010 statement: extension to randomised crossover trials | Clinical trials, Experimental studies | No clinical specialty specified | No report section specified | |
| CONSORT 2010 statement: extension to randomised pilot and feasibility trials | Clinical trials, Experimental studies | No clinical specialty specified | Whole report | |
| CONSORT-CHM | CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration | Clinical trials, Experimental studies | Complementary and alternative medicine | Whole report |
| CONSORT Harms 2022 | CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials | Clinical trials, Experimental studies | No clinical specialty specified | Harms/adverse effects/safety data, Whole report |
| CONSORT Non-pharmacologic treatment interventions | CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts | Clinical trials, Experimental studies | No clinical specialty specified | Abstract, Whole report |
| CONSORT-CENT | CONSORT extension for reporting N-of- 1 trials (CENT) 2015 Statement | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| CENT for TCM | CONSORT extension for reporting N-of- 1 trials for traditional Chinese medicine (CENT for TCM) : Recommendations, explanation and elaboration | Clinical trials, Experimental studies | Complementary and alternative medicine | Whole report |
| CONSORT-ROUTINE | CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE) : checklist with explanation and elaboration | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| CONSORT for abstracts | CONSORT for reporting randomised trials in journal and conference abstracts | Clinical trials, Experimental studies | No clinical specialty specified | Abstract, Conference paper/abstract |
| CONSORT-EHEALTH | CONSORT-EHEALTH : improving and standardizing evaluation reports of Web-based and mobile health interventions | Clinical trials, Experimental studies | No clinical specialty specified | Intervention (exposure) |
| CONSORT-Equity | CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| SPIRIT Factorial | Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement | Study protocols | No clinical specialty specified | Protocol-whole report |
| COREQ | Consolidated criteria for reporting qualitative research (COREQ) : a 32-item checklist for interviews and focus groups | Qualitative research | No clinical specialty specified | Whole report |
| CONSORT Cluster | Consort 2010 statement: extension to cluster randomised trials | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| CoBRA | Developing a guideline to standardize the citation of bioresources in journal articles (CoBRA) | Experimental studies, Observational studies | No clinical specialty specified | Biospecimen/bioresource information |
| STROBE for conference abstracts | Draft STROBE checklist for conference abstracts | Observational studies | No clinical specialty specified | Conference paper/abstract |
| SPIRIT-DEFINE | Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Protocol-whole report |
| CONSORT-DEFINE | Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| PRISMA-LSR | Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR) : checklist and explanation | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| PRISMA-COSMIN for OMIs | Guideline for reporting systematic reviews of outcome measurement instruments (OMIs) : PRISMA-COSMIN for OMIs 2024 | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Abstract, Whole report |
| SPIRIT-PRO | Guidelines for Inclusion of Patient -Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Outcomes (variables) |
| SPIRIT-Outcomes 2022 | Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Outcomes (variables), Statistical methods and analyses |
| CONSORT-Outcomes 2022 | Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension | Clinical trials, Experimental studies | No clinical specialty specified | Outcomes (variables), Results, Statistical methods and analyses |
| CONSERVE | Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID- 19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Whole report |
| SPIRIT-Path | Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension | Clinical trials, Experimental studies, Study protocols | Pathology | Whole report |
| SPIRIT-AI | Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension | Artificial intelligence/Machine learning studies, Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Whole report |
| CONSORT Pragmatic trials | Improving the reporting of pragmatic trials: an extension of the CONSORT statement | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| STROBE-SIIS | International Olympic Committee Consensus Statement: Methods for Recording and Reporting of Epidemiological Data on Injury and Illness in Sports 2020 (Including the STROBE Extension for Sports Injury and Illness Surveillance (STROBE-SIIS)) | Observational studies | Sport and exercise medicine | Whole report |
| STROBE-Vet | Methods and processes of developing the strengthening the reporting of observational studies in epidemiology – veterinary (STROBE-Vet) statement | Observational studies | No clinical specialty specified | Whole report |
| PRISMA-CHM 2020 | PRISMA (Preferred Reporting Items for Systematic Reviews and Meta -Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020) | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Complementary and alternative medicine | Whole report |
| PRISMA 2020 for Abstracts | PRISMA 2020 for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Abstract, Conference paper/abstract |
| PRISMA-ScR | PRISMA Extension for Scoping Reviews (PRISMA-ScR) : Checklist and Explanation | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| PRISMA-M 2020 | PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Complementary and alternative medicine | Whole report |
| PRISMA harms | PRISMA harms checklist: improving harms reporting in systematic reviews | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Harms/adverse effects/safety data |
| PRISMA-Equity 2012 or PRISMA-E 2012 | PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| PRISMA-S | PRISMA-S : an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Procedure/Method |
| PRISMA-IPD | Preferred Reporting Items for Systematic Review and Meta -Analyses of individual participant data: the PRISMA-IPD Statement | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| PRISMA-DTA | Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Abstract, Whole report |
| PRISMA-DTA for Abstracts | Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration | Diagnostic and prognostic studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Abstract |
| RIGHT for Acupuncture | RIGHT for Acupuncture: An Extension of the RIGHT Statement for Clinical Practice Guidelines on Acupuncture | Clinical practice guidelines | Complementary and alternative medicine | Whole report |
| Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost -Effectiveness in Health and Medicine | Economic evaluations | No clinical specialty specified | Whole report | |
| RIGHT-COI&F | Reporting Conflicts of Interest and Funding in Health Care Guidelines: The RIGHT-COI &F Checklist | Clinical practice guidelines | No clinical specialty specified | Conflict of interest, Funding |
| CheckUp | Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp) | Clinical practice guidelines | No clinical specialty specified | Conflict of interest, Narrative sections (discussion etc.), Procedure/Method, Research recommendations |
| CONSORT-AI | Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension | Artificial intelligence/Machine learning studies, Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| PRISMA-A | Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Complementary and alternative medicine | Whole report |
| CONSORT Factorial | Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| Reporting of Multi -Arm Parallel -Group Randomized Trials: Extension of the CONSORT 2010 Statement | Clinical trials, Experimental studies | No clinical specialty specified | Whole report | |
| CONSORT CRXO | Reporting of cluster randomised crossover trials: extension of the CONSORT 2010 statement with explanation and elaboration | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| CONSORT Non-inferiority | Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| CONSORT-PRO | Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension | Clinical trials, Experimental studies | No clinical specialty specified | Outcomes (variables) |
| SW-CRT | Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| SPIRIT-Surrogate | Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate) : extension checklist with explanation and elaboration | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Whole report |
| CONSORT-Surrogate | Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate) : extension checklist with explanation and elaboration | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| CONSORT-SPI 2018 | Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension | Clinical trials, Experimental studies | Behavioural medicine, Psychology | Abstract, Conference paper/abstract, Conflict of interest, Funding, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) |
| CONSORT Herbal | Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT Statement | Clinical trials, Experimental studies | Complementary and alternative medicine | Whole report |
| STRICTA | Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) : extending the CONSORT statement | Clinical trials, Experimental studies | Complementary and alternative medicine | Whole report |
| SPENT | SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Protocol-whole report |
| SQUIRE-EDU | SQUIRE-EDU (Standards for QUality Improvement Reporting Excellence in Education): Publication Guidelines for Educational Improvement | Quality improvement studies | Medical education | Whole report |
| SQUIRE-SIM | SQUIRE-SIM (Standards for Quality Improvement Reporting Excellence for SIMulation) : Publication Guidelines for Simulation -Based Quality Improvement Projects | Quality improvement studies | No clinical specialty specified | Whole report |
| STARD for Abstracts: essential items for reporting diagnostic accuracy studies in journal or conference abstracts | Diagnostic and prognostic studies | No clinical specialty specified | Abstract, Conference paper/abstract | |
| STARD-BLCM | STARD-BLCM : Standards for the Reporting of Diagnostic accuracy studies that use Bayesian Latent Class Models | Diagnostic and prognostic studies, Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| STROBE-AMS | STROBE-AMS : recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship | Observational studies | Infectious diseases | Whole report |
| STREGA | STrengthening the REporting of Genetic Association Studies (STREGA) : An Extension of the STROBE Statement. | Observational studies | Genetics | Narrative sections (discussion etc.), Procedure/Method |
| STROBE-ME | STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME) : An extension of the STROBE statement | Observational studies | Public health | Whole report |
| SPIRIT-TCM | Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018) | Clinical trials, Experimental studies, Study protocols | Complementary and alternative medicine | Protocol-whole report |
| STRICTOC | Standards for reporting interventions in clinical trials of cupping (STRICTOC) : extending the CONSORT statement | Clinical trials, Experimental studies | Complementary and alternative medicine | Intervention (exposure) |
| STROBE-MR | Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement | Observational studies | No clinical specialty specified | Whole report |
| STROBE-NI | Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI) : an extension of the STROBE statement for neonatal infection research | Observational studies | Infectious diseases, Obstetrics and gynaecology, Paediatrics | Ethical issues (consent etc.), Narrative sections (discussion etc.), Procedure/Method, Results |
| STROBE-RDS | Strengthening the Reporting of Observational Studies in Epidemiology for Respondent -Driven Sampling Studies: ‘ STROBE-RDS ’ Statement. | Observational studies | No clinical specialty specified | Whole report |
| STROBE-nut | Strengthening the Reporting of Observational Studies in Epidemiology—Nutritional Epidemiology (STROBE-nut) : An Extension of the STROBE Statement | Observational studies | Nutrition and dietetics | Whole report |
| STROME-ID | Strengthening the reporting of molecular epidemiology for infectious diseases (STROME-ID) : an extension of the STROBE statement | Observational studies | Infectious diseases | Whole report |
| TRIPOD+AI | TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods | Artificial intelligence/Machine learning studies, Diagnostic and prognostic studies, Observational studies | No clinical specialty specified | Whole report |
| The CONSORT Statement: Application within and adaptations for orthodontic trials | Clinical trials, Experimental studies | Dentistry | Whole report | |
| The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report | |
| REFLECT | The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety by modifying the CONSORT statement | No study design specified | No clinical specialty specified | Whole report |
| RECORD | The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement | Observational studies | No clinical specialty specified | Whole report |
| RIGHT-TCM | The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation | Clinical practice guidelines | Complementary and alternative medicine | Intervention (exposure) |
| ACE Statement | The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design | Clinical trials, Experimental studies | No clinical specialty specified | Abstract, Whole report |
| RIGHT for CPM | The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM | Clinical practice guidelines | Complementary and alternative medicine | Whole report |
| RIGHT-PVG | The reporting checklist for public versions of guidelines: RIGHT-PVG | Clinical practice guidelines | No clinical specialty specified | Whole report |
| RECORD-PE | The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE) | Observational studies | Pharmaceutical medicine | Whole report |
| TRIPOD-Cluster | Transparent reporting of multivariable prediction models developed or validated using clustered data: TRIPOD-Cluster checklist | Artificial intelligence/Machine learning studies, Diagnostic and prognostic studies, Observational studies | No clinical specialty specified | Whole report |
| TRIPOD-SRMA | Transparent reporting of multivariable prediction models for individual prognosis or diagnosis: checklist for systematic reviews and meta-analyses (TRIPOD-SRMA) | Artificial intelligence/Machine learning studies, Diagnostic and prognostic studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| CREATE | A Checklist for Reporting Valuation Studies of Multi -Attribute Utility -Based Instruments (CREATE) | Economic evaluations | No clinical specialty specified | Data, Intervention (exposure), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.), Terminology/definitions |
| CROSS | A Consensus -Based Checklist for Reporting of Survey Studies (CROSS) | Observational studies, Qualitative research | No clinical specialty specified | Whole report |
| AGReMA | A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Statistical methods and analyses |
| DIRECT | A Reporting Checklist for Discrete Choice Experiments in Health: The DIRECT Checklist | Economic evaluations, Qualitative research | No clinical specialty specified | Whole report |
| A Scoping Review of Four Decades of Outcomes in Nonsurgical Root Canal Treatment, Nonsurgical Retreatment, and Apexification Studies: Part 3 -A Proposed Framework for Standardized Data Collection and Reporting of Endodontic Outcome Studies | Clinical trials, Experimental studies, Observational studies | Dentistry | Procedure/Method, Results, Study characteristics (participants etc.) | |
| CREMAS | A Systematic Review of Methods and Procedures Used in Ecological Momentary Assessments of Diet and Physical Activity Research in Youth: An Adapted STROBE Checklist for Reporting EMA Studies (CREMAS) | Observational studies | Nutrition and dietetics, Sport and exercise medicine | Whole report |
| A call for transparent reporting to optimize the predictive value of preclinical research | Animal pre-clinical research | No clinical specialty specified | Data, Statistical methods and analyses | |
| ContES checklist | A checklist for assessing the methodological quality of concurrent t ES-fMRI studies (ContES checklist): a consensus study and statement | Experimental studies | Neurology, Radiology | Intervention (exposure), Procedure/Method |
| A checklist to improve reporting of group-based behaviour-change interventions | Experimental studies, Mixed methods studies, Observational studies, Qualitative research | Behavioural medicine | Intervention (exposure), Study characteristics (participants etc.) | |
| A child-centred research checklist to improve the design and reporting of paediatric research studies: A descriptive mixed methods study | No study design specified | Paediatrics | Data, Ethical issues (consent etc.), Procedure/Method, Study characteristics (participants etc.) | |
| A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints | Clinical trials, Experimental studies | Oncology | Terminology/definitions | |
| STREIS | A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement | Observational studies | Genetics | Data, Narrative sections (discussion etc.), Procedure/Method |
| A comprehensive checklist for reporting the use of OSCEs | No study design specified | Medical education | Whole report | |
| DOLBaPP | A consensus approach toward the standardization of back pain definitions for use in prevalence studies | Observational studies, Qualitative research | Rheumatology | Terminology/definitions |
| PITCH | A consensus guideline on preferred items for reporting case series in homeopathy: The PITCH statement | Observational studies | Complementary and alternative medicine | Whole report |
| GSPC | A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible | Animal pre-clinical research | No clinical specialty specified | Whole report |
| A guide for the design and conduct of self-administered surveys of clinicians | Observational studies | No clinical specialty specified | Whole report | |
| A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines | Clinical trials, Experimental studies | No clinical specialty specified | Whole report | |
| A new manner of reporting pressure results after glaucoma surgery | Observational studies | Ophthalmology | Abstract | |
| A new standardized format for reporting hearing outcome in clinical trials | Clinical trials, Experimental studies | Audiovestibular medicine | Data, Outcomes (variables) | |
| A new structure for quality improvement reports | Quality improvement studies | No clinical specialty specified | Whole report | |
| A position paper on standardizing the nonneoplastic kidney biopsy report | No study design specified | Pathology, Renal medicine | No report section specified | |
| A proposed taxonomy of terms to guide the clinical trial recruitment process | Clinical trials, Experimental studies | Palliative care | Terminology/definitions | |
| A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies | Animal pre-clinical research, Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Protocol-whole report | |
| A reporting guide for studies on individual differences in traffic safety | Qualitative research | No clinical specialty specified | Whole report | |
| A reporting guideline for clinical platelet transfusion studies from the BEST Collaborative | Clinical trials, Experimental studies | Haematology, Oncology | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method | |
| A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better? | Clinical trials, Experimental studies, Observational studies | Infectious diseases | Procedure/Method, Results, Study characteristics (participants etc.) | |
| A review of published analyses of case-cohort studies and recommendations for future reporting | Observational studies | No clinical specialty specified | Statistical methods and analyses, Study characteristics (participants etc.) | |
| A scoping review of the use of ethnographic approaches in implementation research and recommendations for reporting | Qualitative research | No clinical specialty specified | Procedure/Method, Results, Statistical methods and analyses | |
| A structured approach to documenting a search strategy for publication: a 12 step guideline for authors | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Procedure/Method | |
| AGReHIIT | A systematic review and cluster analysis approach of 103 studies of high-intensity interval training on cardiorespiratory fitness | Study protocols | Sport and exercise medicine | Narrative sections (discussion etc.), Procedure/Method, Results |
| A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting | Animal pre-clinical research, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report | |
| A systematic review of the reporting of Data Monitoring Committees’ roles, interim analysis and early termination in pediatric clinical trials | Clinical trials, Experimental studies | Paediatrics | Data | |
| ASTAIRE | A tool to analyze the transferability of health promotion interventions | No study design specified | No clinical specialty specified | Data, Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) |
| ACCORD | ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi | Clinical practice guidelines, Qualitative research | No clinical specialty specified | Whole report |
| ACURATE | ACURATE : A guide for reporting sham controls in trials using acupuncture | Clinical trials, Experimental studies | Complementary and alternative medicine | Intervention (exposure) |
| AMWA ‒ EMWA ‒ ISMPP Joint Position Statement on the Role of Professional Medical Writers | No study design specified | No clinical specialty specified | Acknowledgements, Conflict of interest, Ethical issues (consent etc.) | |
| ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis | Clinical trials, Experimental studies | Rheumatology | Data | |
| AdViSHE | AdVi SHE : A Validation -Assessment Tool of Health -Economic Models for Decision Makers and Model Users | Economic evaluations | No clinical specialty specified | Appendix, Statistical methods and analyses |
| Adaptation of the CARE Guidelines for Therapeutic Massage and Bodywork Publications: Efforts To Improve the Impact of Case Reports | Observational studies | Complementary and alternative medicine | Whole report | |
| Adjusting for Treatment Switching in Oncology Trials: A Systematic Review and Recommendations for Reporting | Clinical trials, Experimental studies | Oncology | Statistical methods and analyses | |
| A-URS | Adult Ureteroscopy (A-URS) Checklist: A New Tool To Standardise Reporting in Endourology | Clinical trials, Experimental studies, Observational studies | Surgery, Urology | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) |
| PRIPROID | Advising on Preferred Reporting Items for patient-reported outcome instrument development: the PRIPROID | Clinical trials, Experimental studies, Observational studies, Qualitative research | No clinical specialty specified | Whole report |
| American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS) | No study design specified | Cardiovascular medicine, Radiology | Images, Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) | |
| American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants | No study design specified | Genetics, Obstetrics and gynaecology | Biospecimen/bioresource information | |
| American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation | Clinical trials, Experimental studies | Infectious diseases, Surgery | Ethical issues (consent etc.), Harms/adverse effects/safety data, Outcomes (variables), Terminology/definitions | |
| CARE-DN | An Extension of the CARE Guidelines for Dry Needling Case Reports (CARE-DN) | No study design specified | Complementary and alternative medicine | Whole report |
| An analysis of preclinical efficacy testing of antivenoms for sub -Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management | Animal pre-clinical research | Tropical medicine | Procedure/Method, Results, Study characteristics (participants etc.) | |
| PRIBA | An analysis of reporting practices in the top 100 cited health and medicine-related bibliometric studies from 2019 to 2021 based on a proposed guidelines | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| Liver-FibroSTARD | An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver -FibroSTARD standards | Clinical trials, Diagnostic and prognostic studies, Experimental studies, Observational studies | Hepatology | Whole report |
| An introduction to standardized clinical nomenclature for dysmorphic features: the Elements of Morphology project | No study design specified | Genetics, Obstetrics and gynaecology, Paediatrics, Surgery | Terminology/definitions | |
| An introduction to using Bayesian linear regression with clinical data | Clinical trials, Experimental studies, Other | Psychology | Statistical methods and analyses | |
| ACRE | Anaesthesia Case Report (ACRE) checklist: a tool to promote high-quality reporting of cases in peri-operative practice | Observational studies | Surgery | Whole report |
| Anecdotes as evidence | Observational studies | Pharmaceutical medicine | Harms/adverse effects/safety data | |
| Application of Mixed Methods in Health Services Management Research: A Systematic Review | Mixed methods studies | No clinical specialty specified | Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) | |
| Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit-risk assessment: the BRAINS study including expert workshop | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Harms/adverse effects/safety data, Procedure/Method, Results | |
| Appropriate use and reporting of uncontrolled case series in the medical literature | Observational studies | Ophthalmology | Whole report | |
| Artificial intelligence in dental research: Checklist for authors, reviewers, readers | Artificial intelligence/Machine learning studies | Dentistry | Whole report | |
| Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal | Clinical trials, Experimental studies | No clinical specialty specified | Statistical methods and analyses | |
| Authors’ Submission Toolkit: a practical guide to getting your research published | No study design specified | Pharmaceutical medicine | Whole report | |
| BIAS | BIAS : Transparent reporting of biomedical image analysis challenges | No study design specified | No clinical specialty specified | Whole report |
| BARG | Bayesian Analysis Reporting Guidelines | No study design specified | No clinical specialty specified | Statistical methods and analyses |
| BayesWatch | Bayesian methods in health technology assessment: a review | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Statistical methods and analyses |
| BRIVAC | Benefit -Risk Assessment of Vaccines. Part II : Proposal Towards Consolidated Standards of Reporting Quantitative Benefit -Risk Models Applied to Vaccines (BRIVAC) | No study design specified | Infectious diseases, Pharmaceutical medicine, Public health | Whole report |
| ConPhyMP | Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research -The ConPhy MP-Guidelines | Clinical trials, Experimental studies | Complementary and alternative medicine, Pharmaceutical medicine, Toxicology | Harms/adverse effects/safety data, Intervention (exposure), Terminology/definitions |
| Best Practices in Data Analysis and Sharing in Neuroimaging using MRI | Clinical trials, Experimental studies, Observational studies | Neurology, Radiology | Data, Images, Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.), Terminology/definitions | |
| Best practice guidance and reporting items for the development of scoping review protocols | Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Protocol-whole report | |
| Best practice guidelines for citizen science in mental health research: systematic review and evidence synthesis | Clinical practice guidelines, Clinical trials, Economic evaluations, Experimental studies, Observational studies, Qualitative research, Quality improvement studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Psychiatry, Psychology | Acknowledgements, Data, Ethical issues (consent etc.), Funding, Narrative sections (discussion etc.), Procedure/Method, Title | |
| Best practices in the reporting of participatory action research: Embracing both the forest and the trees | No study design specified | Psychology | Whole report | |
| BiFi REGs | Biofield therapies: Guidelines for reporting clinical trials | Clinical trials, Experimental studies | Complementary and alternative medicine | Intervention (exposure) |
| CARE extension guideline for acupuncture case reports | No study design specified | No clinical specialty specified | Whole report | |
| CARE-radiology | CARE-radiology statement explanation and elaboration: reporting guideline for radiological case reports | Observational studies | Radiology | Whole report |
| CABARET | CAse-BAsed REview sTandards (CABARET) : Considerations for Authors, Reviewers, and Editors | Observational studies | No clinical specialty specified | Whole report |
| CODE-EHR | CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Data, Ethical issues (consent etc.), Statistical methods and analyses, Terminology/definitions |
| CONFERD-HP | CONFERD-HP : recommendations for reporting COmpeteNcy FramEwoRk Development in health professions | Mixed methods studies, Qualitative research | Medical education | Whole report |
| CONSORT-Children and Adolescents | CONSORT-Children and Adolescents | No study design specified | No clinical specialty specified | No report section specified |
| CORE-CERT | CORE-CERT Items as a Minimal Requirement for Replicability of Exercise Interventions: Results From Application to Exercise Studies for Breast Cancer Patients | Clinical trials, Experimental studies | Oncology, Physiotherapy, Sport and exercise medicine | Intervention (exposure) |
| COSMIN | COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures | Observational studies, Qualitative research, Reliability and agreement studies | No clinical specialty specified | Whole report |
| Calibration methods used in cancer simulation models and suggested reporting guidelines | No study design specified | Oncology | Data, Procedure/Method | |
| Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study | No study design specified | Infectious diseases | Harms/adverse effects/safety data, Terminology/definitions | |
| Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy | No study design specified | Gastroenterology | Harms/adverse effects/safety data, Intervention (exposure), Procedure/Method, Results | |
| Capturing momentary, self-report data: a proposal for reporting guidelines | Observational studies, Qualitative research | Behavioural medicine | Data, Intervention (exposure), Procedure/Method | |
| Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance | Clinical trials, Experimental studies | No clinical specialty specified | Funding | |
| ChecKAP | Chec KAP : A Checklist for Reporting a Knowledge, Attitude, and Practice (KAP) Study | Qualitative research | Public health | Whole report |
| CLEAR | CheckList for EvaluAtion of Radiomics research (CLEAR) : a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSo MII | No study design specified | Radiology | Whole report |
| CLAIM | Checklist for Artificial Intelligence in Medical Imaging (CLAIM) : 2024 Update | Artificial intelligence/Machine learning studies | Radiology | Whole report |
| COHERE | Checklist for One Health Epidemiological Reporting of Evidence (COHERE) | Observational studies | Public health | Acknowledgements, Ethical issues (consent etc.), Narrative sections (discussion etc.), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) |
| CRT-EE | Checklist for Theoretical Report in Epidemiological Studies (CRT-EE) : explanation and elaboration | Clinical trials, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| CEDRIC-HIV | Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use | Clinical trials, Experimental studies, Observational studies | Infectious diseases, Public health | Whole report |
| Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT | Clinical trials, Experimental studies | No clinical specialty specified | Intervention (exposure), Narrative sections (discussion etc.), Outcomes (variables), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) | |
| Clarity in Reporting Terminology and Definitions of Set End Points in Resistance Training | Clinical trials, Experimental studies, Observational studies, Other | Sport and exercise medicine | Terminology/definitions | |
| Clinical trials focusing on cancer pain educational interventions: core components to include during planning and reporting | Clinical trials, Experimental studies | Oncology | Whole report | |
| CLIX-M | Clinician-informed explainable artificial intelligence evaluation checklist with metrics (CLIX-M) for AI-powered clinical decision support systems | Artificial intelligence/Machine learning studies, Diagnostic and prognostic studies, Observational studies | No clinical specialty specified | Whole report |
| Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report | |
| Commentary: minimum reporting standards should be expected for preclinical radiobiology irradiators and dosimetry in the published literature | Animal pre-clinical research | Oncology | Harms/adverse effects/safety data, Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) | |
| Common data elements for posttraumatic stress disorder research | No study design specified | Psychiatry | Data | |
| Community-developed checklists for publishing images and image analyses | No study design specified | No clinical specialty specified | Images | |
| Completeness of reporting of radiation therapy planning, dose, and delivery in veterinary radiation oncology manuscripts from 2005 to 2010 | Clinical trials, Experimental studies | No clinical specialty specified | Intervention (exposure) | |
| CERT-PFMT | Comprehensive reporting of pelvic floor muscle training for urinary incontinence: CERT-PFMT | Clinical trials, Experimental studies | Physiotherapy, Sport and exercise medicine, Urology | Intervention (exposure) |
| GAMING | Conceptual Ambiguity Surrounding Gamification and Serious Games in Health Care: Literature Review and Development of Game -Based Intervention Reporting Guidelines (GAMING) | Clinical trials, Experimental studies, Qualitative research | No clinical specialty specified | Intervention (exposure) |
| Conducting and reporting case series and audits–author guidelines for acupuncture in medicine | Observational studies | Complementary and alternative medicine | Whole report | |
| Conflict of Interest in Peer -Reviewed Medical Journals | No study design specified | No clinical specialty specified | Conflict of interest | |
| Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis | Clinical trials, Experimental studies | Haematology, Oncology | Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) | |
| Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting | Clinical trials, Diagnostic and prognostic studies, Experimental studies | Haematology, Oncology | Procedure/Method, Results | |
| CERT | Consensus on Exercise Reporting Template (CERT) : Modified Delphi Study | Clinical trials, Experimental studies | Sport and exercise medicine | Intervention (exposure) |
| CORDES | Consensus on Recording Deep Endometriosis Surgery: the CORDES statement | Clinical trials, Experimental studies | Obstetrics and gynaecology, Surgery | Intervention (exposure), Procedure/Method, Results, Study characteristics (participants etc.), Terminology/definitions |
| CRED-nf checklist | Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist) | Clinical trials, Experimental studies | Neurology, Psychology | Data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) |
| Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 | Clinical trials, Experimental studies | Haematology, Oncology | Whole report | |
| PHELIX | Consensus reporting guidelines to address gaps in descriptions of ultra-rare genetic conditions | Observational studies | Genetics, Paediatrics | Data, Study characteristics (participants etc.) |
| Consensus statement: Defining minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass | No study design specified | Cardiovascular medicine, Surgery | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables) | |
| CARC | Consensus-based recommendations for case report in Chinese medicine (CARC) | Observational studies | Complementary and alternative medicine | Whole report |
| Consensus-based reporting guideline for participatory development and evaluation of digital health interventions | No study design specified | No clinical specialty specified | Whole report | |
| STRADAS-paraTB | Consensus-based reporting standards for diagnostic test accuracy studies for paratuberculosis in ruminants | Diagnostic and prognostic studies | No clinical specialty specified | Whole report |
| Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies -Statement From ATVB Council | Animal pre-clinical research | Cardiovascular medicine | Data | |
| CHEERS-AI | Consolidated Health Economic Evaluation Reporting Standards for Interventions that use Artificial Intelligence (CHEERS-AI) | Artificial intelligence/Machine learning studies, Economic evaluations | No clinical specialty specified | Whole report |
| Consolidated Reporting Guidelines for Prognostic and Diagnostic Machine Learning Modeling Studies: Development and Validation | Artificial intelligence/Machine learning studies, Diagnostic and prognostic studies | No clinical specialty specified | Whole report | |
| CONSIDER | Consolidated criteria for strengthening reporting of health research involving indigenous peoples: the CONSIDER statement | Diagnostic and prognostic studies, Experimental studies, Mixed methods studies, Observational studies, Qualitative research, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Data, Ethical issues (consent etc.), Funding, Harms/adverse effects/safety data, Narrative sections (discussion etc.), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) |
| COS-STAP Statement | Core Outcome Set -STAndardised Protocol Items: the COS-STAP Statement | Study protocols | No clinical specialty specified | Protocol-whole report |
| COS-STAR | Core Outcome Set -STAndards for Reporting: The COS-STAR Statement | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| CReDECI 2 | Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare: revised guideline (CReDECI 2) | Clinical trials, Experimental studies | No clinical specialty specified | Intervention (exposure) |
| Criteria for describing and evaluating training interventions in healthcare professions – CRe-DEPTH | Clinical trials, Observational studies, Qualitative research | No clinical specialty specified | Intervention (exposure) | |
| Criteria for evaluation of novel markers of cardiovascular risk | Observational studies | Cardiovascular medicine | Outcomes (variables), Procedure/Method, Results | |
| DELTA2 | DELTA 2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Statistical methods and analyses |
| DID-METAB | DID-METAB Checklist | Observational studies | Nutrition and dietetics | Whole report |
| Data Processing Strategies to Determine Maximum Oxygen Uptake: A Systematic Scoping Review and Experimental Comparison with Guidelines for Reporting | Clinical trials, Experimental studies, Observational studies | Sport and exercise medicine | Data | |
| Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting | Observational studies | Pharmaceutical medicine | Data | |
| Defining Group Care Programs: An Index of Reporting Standards | Clinical trials, Experimental studies | No clinical specialty specified | Intervention (exposure), Outcomes (variables), Study characteristics (participants etc.) | |
| Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations | Observational studies | Renal medicine | Data, Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Definition and classification of intraoperative complications (CLASSIC) : Delphi study and pilot evaluation | Clinical trials, Experimental studies, Observational studies | Surgery | Harms/adverse effects/safety data, Terminology/definitions | |
| Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet | Clinical trials, Experimental studies | Oncology | Statistical methods and analyses, Terminology/definitions | |
| DELPHISTAR | Delphi studies in social and health sciences -Recommendations for an interdisciplinary standardized reporting (DELPHISTAR) . Results of a Delphi study | Clinical practice guidelines, Qualitative research | No clinical specialty specified | Whole report |
| Describing deprescribing trials better: an elaboration of the CONSORT statement | Clinical trials, Experimental studies | No clinical specialty specified | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.) | |
| Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics | Economic evaluations | Obstetrics and gynaecology | Whole report | |
| Designing and reporting case series in plastic surgery | Observational studies | Surgery | Whole report | |
| CREAM | Developing Consensus -Based Guidelines for Case Reporting in Aesthetic Medicine: Enhancing Transparency and Standardization | Observational studies | Dermatology, Surgery | Whole report |
| Developing a methodological framework for organisational case studies: a rapid review and consensus development process | Mixed methods studies, Observational studies, Qualitative research, Quality improvement studies | No clinical specialty specified | Data, Procedure/Method, Results, Statistical methods and analyses | |
| CORE Reference | Developing the Clarity and Openness in Reporting: E3-based (CORE) reference user manual for creation of clinical study reports in the era of clinical trial transparency | Clinical trials, Experimental studies | No clinical specialty specified | Whole report |
| TIDieR-Rehab | Developing the TIDieR-Rehab checklist: a modified Delphi process to extend the Template for Intervention Description and Replication (TIDieR) for rehabilitation intervention reporting | Clinical trials, Experimental studies, Observational studies | Occupational therapy, Physiotherapy, Psychology, Rehabilitation medicine | Harms/adverse effects/safety data, Intervention (exposure), Study characteristics (participants etc.) |
| Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data | No study design specified | No clinical specialty specified | Whole report | |
| ObsQual | Development and validation of observational and qualitative study protocol reporting checklists for novice researchers (ObsQual checklist) | Observational studies, Qualitative research, Study protocols | No clinical specialty specified | Whole report |
| Development and validation of reporting guidelines for studies involving data linkage | No study design specified | No clinical specialty specified | Data | |
| GREET | Development and validation of the guideline for reporting evidence-based practice educational interventions and teaching (GREET) | Clinical trials, Experimental studies, Observational studies, Other, Quality improvement studies, Study protocols | No clinical specialty specified | Intervention (exposure) |
| GROVE | Development of GROVE : A Guideline for RepOrting Vignette Experiments conducted in a healthcare context | Experimental studies | No clinical specialty specified | Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) |
| ConMapT | Development of a Reporting Guideline for Trochim’s Concept Mapping | Mixed methods studies | No clinical specialty specified | Whole report |
| PRISMA-ATCM | Development of a reporting guideline for systematic reviews of animal experiments in the field of traditional Chinese medicine | Animal pre-clinical research, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| Development of guidelines to reduce, handle and report missing data in palliative care trials: A multi-stakeholder modified nominal group technique | Clinical trials, Experimental studies | Oncology, Palliative care | Data, Narrative sections (discussion etc.), Results, Statistical methods and analyses | |
| ASSESS | Development of the ASSESS tool: a comprehenSive tool to Support rEporting and critical appraiSal of qualitative, quantitative, and mixed methods implementation reSearch outcomes | Clinical trials, Economic evaluations, Experimental studies, Mixed methods studies, Observational studies, Qualitative research, Quality improvement studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| AQUA | Development of the Anatomical Quality Assurance (AQUA) Checklist: guidelines for reporting original anatomical studies | Observational studies | Pathology, Radiology, Surgery | Whole report |
| CLARIFY 2021 | Development of the CLARIFY (CheckList stAndardising the Reporting of Interventions For Yoga) guidelines: a Delphi study | Clinical trials, Experimental studies, Observational studies | Sport and exercise medicine | Intervention (exposure) |
| RIVA-C | Development of the Reporting Infographics and Visual Abstracts of Comparative studies (RIVA-C) checklist and guide | Clinical trials, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Abstract |
| STROND | Development of the Standards of Reporting of Neurological Disorders (STROND) checklist: A guideline for the reporting of incidence and prevalence studies in neuroepidemiology | Observational studies | Neurology | Whole report |
| DEAL | Development, Evaluation, and Assessment of Large Language Models (DEAL) Checklist | Artificial intelligence/Machine learning studies, Diagnostic and prognostic studies | No clinical specialty specified | Whole report |
| PLIRT | Development, explanation, and presentation of the Physical Literacy Interventions Reporting Template (PLIRT) | Clinical trials, Experimental studies, Qualitative research | Sport and exercise medicine | No report section specified |
| Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet | Clinical trials, Experimental studies | Haematology, Oncology | Intervention (exposure), Outcomes (variables), Procedure/Method | |
| Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data | No study design specified | Infectious diseases | Harms/adverse effects/safety data, Terminology/definitions | |
| CONFIDE | Disaster medicine reporting: the need for new guidelines and the CONFIDE statement | Observational studies | Emergency medicine | Whole report |
| Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine | No study design specified | Obstetrics and gynaecology, Oncology | No report section specified | |
| CLIP Principles | Documenting Clinical and Laboratory Images in Publications: The CLIP Principles | No study design specified | No clinical specialty specified | Images |
| EACTS / ESCVS best practice guidelines for reporting treatment results in the thoracic aorta | No study design specified | Cardiovascular medicine, Surgery | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting | No study design specified | Nuclear medicine | Images, Procedure/Method, Results | |
| EANM procedure guidelines for brain neurotransmission SPECT using I-labelled dopamine transporter ligands, version 2 | No study design specified | Neurology, Nuclear medicine, Radiology | Images, Procedure/Method, Results, Study characteristics (participants etc.) | |
| ELEVATE-GenAI | ELEVATE-GenAI | Artificial intelligence/Machine learning studies, Economic evaluations | No clinical specialty specified | Whole report |
| ENLIGHT | ENLIGHT : A consensus checklist for reporting laboratory-based studies on the non-visual effects of light in humans | No study design specified | Ophthalmology, Psychology | Intervention (exposure), Study characteristics (participants etc.) |
| GROW | ESMO Guidance for Reporting Oncology real -World evidence (GROW) | Observational studies | Oncology | Whole report |
| EMERGE | ESPACOMP Medication Adherence Reporting Guideline (EMERGE) | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology | Diagnostic and prognostic studies | Rheumatology | Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) | |
| EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology | Observational studies | Rheumatology | Data, Harms/adverse effects/safety data, Procedure/Method, Statistical methods and analyses, Study characteristics (participants etc.) | |
| EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology | Observational studies | Rheumatology | Whole report | |
| EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs) | Clinical trials, Diagnostic and prognostic studies, Experimental studies, Observational studies | Rheumatology | Whole report | |
| EVIDENCE | EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration | Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| Early phase clinical trials extension to guidelines for the content of statistical analysis plans | Clinical trials, Experimental studies | No clinical specialty specified | Statistical analysis plan-whole report | |
| Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting | Clinical trials, Economic evaluations, Experimental studies | No clinical specialty specified | Whole report | |
| Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting | Economic evaluations | No clinical specialty specified | No report section specified | |
| Electrodermal activity at acupoints: literature review and recommendations for reporting clinical trials | Clinical trials, Experimental studies | Complementary and alternative medicine | Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.) | |
| Eliciting the child’s voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient -Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative | Clinical trials, Experimental studies | Oncology, Paediatrics | Harms/adverse effects/safety data, Terminology/definitions | |
| Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate -Specific Antigen Working Group | Clinical trials, Experimental studies | Oncology, Urology | Outcomes (variables), Study characteristics (participants etc.) | |
| Endo -STAR | Clinical trials, Experimental studies, Study protocols | No clinical specialty specified | Protocol-whole report | |
| Endovascular repair compared with operative repair of traumatic rupture of the thoracic aorta: a nonsystematic review and a plea for trauma-specific reporting guidelines | No study design specified | Emergency medicine, Surgery | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables) | |
| VAS-NPH | Enhancing the quality of evidence, comparability, and reproducibility in ventriculoatrial shunt research for normal pressure hydrocephalus: A systematic review and VAS-NPH reporting guideline | Experimental studies, Observational studies | Neurology, Surgery | Whole report |
| RISE2 Genomics | Ensuring best practice in genomics education and evaluation: reporting item standards for education and its evaluation in genomics (RISE 2 Genomics) | Experimental studies, Mixed methods studies, Observational studies, Qualitative research | Medical education | Whole report |
| DEPICT 2 | Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT | Clinical trials, Experimental studies | Pharmaceutical medicine | Intervention (exposure) |
| GIATE | Establishing a knowledge trail from molecular experiments to clinical trials | Animal pre-clinical research, Clinical trials, Experimental studies, Other | No clinical specialty specified | Data |
| DESCRIBE | Establishing reporting standards for participant characteristics in post-stroke aphasia research: An international e -Delphi exercise and consensus meeting | Clinical trials, Experimental studies, Observational studies, Qualitative research | Neurology, Rehabilitation medicine | Study characteristics (participants etc.) |
| MORECare | Evaluating complex interventions in end of life care: the MORECare statement on good practice generated by a synthesis of transparent expert consultations and systematic reviews | Experimental studies, Mixed methods studies, Observational studies | Palliative care | Ethical issues (consent etc.), Outcomes (variables), Procedure/Method, Statistical methods and analyses, Study characteristics (participants etc.) |
| Evaluating the quality of reporting occupational therapy randomized controlled trials by expanding the CONSORT criteria | Clinical trials, Experimental studies | Occupational therapy | Whole report | |
| CLINIC-STRA-SVF | Evaluating the quality of studies reporting on clinical applications of stromal vascular fraction: A systematic review and proposed reporting guidelines (CLINIC-STRA-SVF) | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| Evaluation of post-introduction COVID- 19 vaccine effectiveness: Summary of interim guidance of the World Health Organization | Observational studies | Infectious diseases, Public health | Whole report | |
| Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer -Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging | Clinical trials, Experimental studies | Oncology, Radiology | Images | |
| EBPQI | Evidence -Based Practice Quality Improvement Reporting Guidelines | No clinical specialty specified | Whole report | |
| Evidence-based behavioral medicine: what is it and how do we achieve it? | Clinical trials, Experimental studies | Behavioural medicine | Whole report | |
| SAMBR | Evidence-based statistical analysis and methods in biomedical research (SAMBR) checklists according to design features | Clinical trials, Diagnostic and prognostic studies, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Data, Statistical methods and analyses |
| Evolving guidelines for publication of qualitative research studies in psychology and related fields | Qualitative research | Psychology | Whole report | |
| Exercise therapy and low back pain: insights and proposals to improve the design, conduct, and reporting of clinical trials | Clinical trials, Experimental studies | Rheumatology, Sport and exercise medicine | Intervention (exposure), Outcomes (variables), Study characteristics (participants etc.) | |
| Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure | Clinical trials, Diagnostic and prognostic studies, Experimental studies, Observational studies | Cardiovascular medicine, Radiology | Whole report | |
| STRICTOM | Extending the CONSORT Statement to moxibustion | Clinical trials, Experimental studies | Complementary and alternative medicine | Intervention (exposure) |
| Figures in clinical trial reports: current practice & scope for improvement | Clinical trials, Experimental studies | No clinical specialty specified | Figures/Graphs | |
| Financial Conflicts of Interest Checklist 2010 for clinical research studies | Clinical trials, Experimental studies | No clinical specialty specified | Conflict of interest | |
| Finding What Works in Health Care: Standards for Systematic Reviews. Chapter 5 – Standards for Reporting Systematic Reviews | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report | |
| GNOSIS | GNOSIS : Guidelines for Neuro -Oncology : Standards for Investigational Studies – reporting of surgically based therapeutic clinical trials | Clinical trials, Experimental studies | Neurology, Oncology, Surgery | Whole report |
| GNOSIS | GNOSIS : guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials | Clinical trials, Experimental studies | Neurology, Oncology | Whole report |
| GRIPP2 | GRIPP 2 reporting checklists: tools to improve reporting of patient and public involvement in research | Clinical practice guidelines, Clinical trials, Economic evaluations, Experimental studies, Observational studies, Qualitative research, Quality improvement studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Abstract, Narrative sections (discussion etc.), Procedure/Method, Results, Study characteristics (participants etc.) |
| Gene expression-based prognostic signatures in lung cancer: ready for clinical use? | Observational studies | Genetics, Oncology, Respiratory medicine | Whole report | |
| Generate Analysis -Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Data | |
| Good Publication Practice (GPP) Guidelines for Company -Sponsored Biomedical Research: 2022 Update | No study design specified | No clinical specialty specified | Acknowledgements, Conflict of interest, Ethical issues (consent etc.) | |
| Good laboratory practice: preventing introduction of bias at the bench | Animal pre-clinical research | Neurology | Conflict of interest, Procedure/Method, Study characteristics (participants etc.) | |
| Good practice in the conduct and reporting of survey research | Observational studies | No clinical specialty specified | Whole report | |
| Good research practices for comparative effectiveness research: Defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources | Clinical trials, Experimental studies, Observational studies, Other | No clinical specialty specified | Whole report | |
| Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report | Economic evaluations | Pharmaceutical medicine | Whole report | |
| Graphics and statistics for cardiology: designing effective tables for presentation and publication | No study design specified | Cardiovascular medicine | Figures/Graphs | |
| Guidance for publishing qualitative research in informatics | Qualitative research | Health informatics | Whole report | |
| GUIDED | Guidance for reporting intervention development studies in health research (GUIDED) : an evidence-based consensus study | Clinical trials, Experimental studies, Observational studies, Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Intervention (exposure) |
| CREDES | Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review | Clinical practice guidelines | Palliative care | Procedure/Method |
| Guidance on reporting ultrasound exposure conditions for bio-effects studies | No study design specified | Radiology | Data, Harms/adverse effects/safety data, Intervention (exposure), Procedure/Method | |
| Guidance to develop individual dose recommendations for patients on chronic hemodialysis | Observational studies | Haematology, Pharmaceutical medicine, Renal medicine | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.) | |
| Guideline for RSA and CT-RSA implant migration measurements: an update of standardizations and recommendations | Clinical trials, Diagnostic and prognostic studies, Experimental studies, Observational studies | Radiology, Rheumatology, Surgery | Abstract, Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.), Title | |
| CIRCLe SMT | Guideline for Reporting Interventions on Spinal Manipulative Therapy: Consensus on Interventions Reporting Criteria List for Spinal Manipulative Therapy (CIRCLe SMT) | Clinical trials, Experimental studies | Physiotherapy | Intervention (exposure) |
| GATHER | Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement | Observational studies | No clinical specialty specified | Data, Narrative sections (discussion etc.), Results, Statistical methods and analyses, Study characteristics (participants etc.) |
| Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research: A Multidisciplinary View | Artificial intelligence/Machine learning studies, Diagnostic and prognostic studies | No clinical specialty specified | Statistical methods and analyses, Whole report | |
| GIST | Guidelines for Intersectional Analysis in Science and Technology | No study design specified | No clinical specialty specified | Whole report |
| GRAPH | Guidelines for Reporting Articles on Psychiatry and Heart rate variability (GRAPH) : recommendations to advance research communication | Observational studies | Behavioural medicine, Cardiovascular medicine, Psychiatry | Data, Procedure/Method, Statistical methods and analyses, Study characteristics (participants etc.) |
| GROESBE | Guidelines for Reporting Oral Epidemiologic Studies to Inform Burden Estimation (GROESBE) | Observational studies | Dentistry | Whole report |
| GRoLTS | Guidelines for Reporting on Latent Trajectory Studies (GRoLTS) | No study design specified | No clinical specialty specified | Data, Results, Statistical methods and analyses |
| GRoNC | Guidelines for Reporting on Norm -Referenced and Criterion -Referenced Scores | No study design specified | No clinical specialty specified | Whole report |
| Guidelines for assessment of bone microstructure in rodents using micro-computed tomography | Animal pre-clinical research | Rheumatology | Images, Procedure/Method, Results, Terminology/definitions | |
| Guidelines for clinical case reports in behavioral clinical psychology | Observational studies | Behavioural medicine, Psychology | Whole report | |
| Guidelines for conducting and reporting economic evaluation of fall prevention strategies | Economic evaluations | Rheumatology | No report section specified | |
| Guidelines for conducting and reporting mixed research in the field of counseling and beyond | Experimental studies, Mixed methods studies, Observational studies, Other, Qualitative research | Psychology | Whole report | |
| MEDQUARG | Guidelines for field surveys of the quality of medicines: a proposal | Observational studies | Pharmaceutical medicine | Whole report |
| Guidelines for reporting an f MRI study | No study design specified | Neurology, Psychiatry, Psychology, Radiology | Data, Ethical issues (consent etc.), Figures/Graphs, Images, Procedure/Method, Results, Study characteristics (participants etc.) | |
| MedinAI | Guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services: Medin AI development, validation and statement | Artificial intelligence/Machine learning studies | No clinical specialty specified | No report section specified |
| Guidelines for reporting case series of tumours of the colon and rectum | Observational studies | Gastroenterology, Oncology, Surgery | Data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.) | |
| Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose | Observational studies | Cardiovascular medicine, Emergency medicine, Pharmaceutical medicine, Toxicology | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Study characteristics (participants etc.) | |
| Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology | Observational studies | Emergency medicine, Pharmaceutical medicine, Renal medicine, Toxicology | Whole report | |
| Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation | No study design specified | Cardiovascular medicine, Surgery | Data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.) | |
| Guidelines for reporting embedded recruitment trials | Clinical trials, Experimental studies | No clinical specialty specified | Whole report | |
| GREOM | Guidelines for reporting evaluations based on observational methodology | Observational studies | No clinical specialty specified | Intervention (exposure), Procedure/Method, Results |
| Guidelines for reporting meta-epidemiological methodology research | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report | |
| Guidelines for reporting non-randomised studies | Clinical trials, Experimental studies, Other | No clinical specialty specified | Whole report | |
| mERA | Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (m ERA) checklist | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Intervention (exposure) |
| GRAFT | Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols | Animal pre-clinical research | Gastroenterology | Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) |
| GRRAS | Guidelines for reporting reliability and agreement studies (GRRAS) were proposed | Reliability and agreement studies | No clinical specialty specified | Whole report |
| Guidelines for reporting research using systematic coding of observed human behaviour (SCOBe) | Observational studies | No clinical specialty specified | Data, Procedure/Method | |
| Guidelines for reporting results of quality of life assessments in clinical trials | Clinical trials, Experimental studies | No clinical specialty specified | Whole report | |
| Guidelines for submitting adverse event reports for publication | Observational studies | Pharmaceutical medicine | Harms/adverse effects/safety data | |
| Guidelines for the Content of Statistical Analysis Plans in Clinical Trials | Clinical trials, Experimental studies | No clinical specialty specified | Statistical analysis plan-whole report | |
| Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods | Clinical trials, Experimental studies, Other | Nutrition and dietetics | Whole report | |
| Guidelines for the reporting of renal artery revascularization in clinical trials | Clinical trials, Experimental studies | Radiology, Renal medicine, Surgery | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Guidelines for the reporting of treatment trials for alcohol use disorders | Clinical trials, Experimental studies | Behavioural medicine, Psychiatry, Psychology, Public health | Whole report | |
| Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders | No study design specified | Neurology | Biospecimen/bioresource information, Whole report | |
| CARDA | Guiding document analyses in health professions education research | Mixed methods studies, Qualitative research, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Medical education | Whole report |
| Head, neck, and brain tumor embolization guidelines | Clinical trials, Experimental studies | Neurology, Oncology, Radiology, Surgery | Terminology/definitions | |
| Health -Economic Analyses of Diagnostics: Guidance on Design and Reporting | Economic evaluations | No clinical specialty specified | Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) | |
| Heterogeneity in the Identification of Potential Drug -Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations | Observational studies | No clinical specialty specified | Procedure/Method, Study characteristics (participants etc.) | |
| HOM-CASE | Homeopathic clinical case reports: Development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline | Observational studies | Complementary and alternative medicine | Whole report |
| CLUDA | How to Report Data on Bilateral Procedures and Other Issues with Clustered Data: The CLUDA Reporting Guidelines | Observational studies | Surgery | Data, Narrative sections (discussion etc.), Results, Statistical methods and analyses |
| How to Report Light Exposure in Human Chronobiology and Sleep Research Experiments | No study design specified | Psychology | Data, Intervention (exposure), Procedure/Method | |
| How to formulate research recommendations | No study design specified | No clinical specialty specified | Research recommendations | |
| How to report low-level laser therapy (LLLT) /photomedicine dose and beam parameters in clinical and laboratory studies | Clinical trials, Experimental studies | No clinical specialty specified | Intervention (exposure) | |
| How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines | Clinical practice guidelines | No clinical specialty specified | Whole report | |
| ICMJE : Uniform Format for Disclosure of Competing Interests in ICMJE Journals | No study design specified | No clinical specialty specified | Conflict of interest | |
| ITRUSST | ITRUSST consensus on standardised reporting for transcranial ultrasound stimulation | Animal pre-clinical research, Observational studies | Neurology, Radiology | Intervention (exposure) |
| Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10 -Year Update | No study design specified | Oncology, Radiology | Harms/adverse effects/safety data, Images, Intervention (exposure), Outcomes (variables), Results, Statistical methods and analyses, Study characteristics (participants etc.), Terminology/definitions | |
| Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data | No study design specified | Infectious diseases | Harms/adverse effects/safety data, Terminology/definitions | |
| PERSiST | Implementing the 27 PRISMA 2020 Statement items for systematic reviews in the sport and exercise medicine, musculoskeletal rehabilitation and sports science fields: the PERSiST (implementing Prisma in Exercise, Rehabilitation, Sport medicine and SporTs science) guidance | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Physiotherapy, Rheumatology, Sport and exercise medicine | Whole report |
| POSORT | Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines | Clinical trials, Experimental studies, Observational studies | Obstetrics and gynaecology | Whole report |
| LAG-R | Improving laboratory animal genetic reporting: LAG-R guidelines | Animal pre-clinical research | No clinical specialty specified | Procedure/Method, Study characteristics (participants etc.), Terminology/definitions |
| eMERGe | Improving reporting of Meta -Ethnography : The e MERGe Reporting Guidance | Qualitative research | No clinical specialty specified | Whole report |
| Improving research practice in rat orthotopic and partial orthotopic liver transplantation: a review, recommendation, and publication guide | Animal pre-clinical research | Hepatology | Whole report | |
| Improving the Development, Monitoring and Reporting of Stroke Rehabilitation Research: Consensus -Based Core Recommendations from the Stroke Recovery and Rehabilitation Roundtable | Clinical trials, Experimental studies | Neurology, Rehabilitation medicine | Intervention (exposure) | |
| CRISP | Improving the Reporting of Primary Care Research: Consensus Reporting Items for Studies in Primary Care-the CRISP Statement | Clinical trials, Experimental studies, Mixed methods studies, Observational studies, Qualitative research | Primary care | Whole report |
| CLIMBR | Improving the Rigor of Mechanistic Behavioral Science: The Introduction of the Checklist for Investigating Mechanisms in Behavior -Change Research (CLIMBR) | Clinical trials, Experimental studies, Observational studies | Behavioural medicine | Whole report |
| CHERRIES | Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES) | Observational studies | No clinical specialty specified | Data, Intervention (exposure), Procedure/Method, Results, Study characteristics (participants etc.) |
| Improving the reporting of clinical case series | Observational studies | Ophthalmology | Data | |
| IMPRINT | Improving the reporting of clinical trials of infertility treatments (IMPRINT) : modifying the CONSORT statement | Clinical trials, Experimental studies | Obstetrics and gynaecology | Whole report |
| Improving the reporting of therapeutic exercise interventions in rehabilitation research | Clinical trials, Experimental studies, Observational studies | Physiotherapy, Rehabilitation medicine, Sport and exercise medicine | Intervention (exposure) | |
| TREND | Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement | Clinical trials, Experimental studies, Other | Behavioural medicine, Public health | Whole report |
| REGEMA | Improving the reporting quality of reliability generalization meta-analyses: The REGEMA checklist | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal | Clinical trials, Experimental studies | No clinical specialty specified | Appendix, Procedure/Method | |
| Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies | Economic evaluations | No clinical specialty specified | Whole report | |
| NOECO | Initial Standardized Framework for Reporting Social Media Analytics in Emergency Care Research | Mixed methods studies, Qualitative research | Emergency medicine | Whole report |
| Instructions to authors for case reporting are limited: a review of a core journal list | Observational studies | No clinical specialty specified | Whole report | |
| Instrumental variable methods in comparative safety and effectiveness research | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Statistical methods and analyses | |
| International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020) | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Harms/adverse effects/safety data, Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) | |
| International Society for Medical Publication Professionals Code of Ethics | No study design specified | No clinical specialty specified | Acknowledgements, Conflict of interest, Ethical issues (consent etc.) | |
| International Spinal Cord Injury Core Data Set (version 3.0) – including standardization of reporting | No study design specified | Neurology | Data, Results, Study characteristics (participants etc.) | |
| Intraoperative fluorescence diagnosis in the brain: a systematic review and suggestions for future standards on reporting diagnostic accuracy and clinical utility | Diagnostic and prognostic studies | Neurology, Surgery | Intervention (exposure), Procedure/Method, Statistical methods and analyses | |
| SoNHR | Introducing So NHR-Reporting guidelines for Social Networks In Health Research | Observational studies, Qualitative research | No clinical specialty specified | Data, Ethical issues (consent etc.), Procedure/Method, Results, Statistical methods and analyses |
| Irreversible Electroporation (IRE) : Standardization of Terminology and Reporting Criteria for Analysis and Comparison | No study design specified | Oncology, Radiology | Data, Images, Terminology/definitions | |
| Journal article reporting standards for qualitative primary, qualitative meta-analytic, and mixed methods research in psychology: The APA Publications and Communications Board task force report | Mixed methods studies, Qualitative research, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Psychology | Whole report | |
| JARS-Quant | Journal article reporting standards for quantitative research in psychology: The APA Publications and Communications Board task force report | Clinical trials, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Psychology | Whole report |
| LETTERS | LETter To the EditoR Standards (LETTERS) : Considerations for Authors, Reviewers, and Editors | Letters to the editor/Correspondence | No clinical specialty specified | Whole report |
| LEVEL | LEVEL (Logical Explanations & Visualizations of Estimates in Linear mixed models): recommendations for reporting multilevel data and analyses | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Data, Statistical methods and analyses |
| Latent Class Analysis: An example for reporting results | Observational studies | Pharmaceutical medicine | Data, Statistical methods and analyses | |
| Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries | Observational studies | Rheumatology | Whole report | |
| MET-RADS-P | METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer | Clinical trials, Experimental studies | Nuclear medicine, Oncology, Radiology, Urology | Images |
| MINIMAR | MINIMAR (MINimum Information for Medical AI Reporting): Developing reporting standards for artificial intelligence in health care | Artificial intelligence/Machine learning studies | No clinical specialty specified | Data, Statistical methods and analyses, Study characteristics (participants etc.) |
| Making economic evaluations more helpful for treatment choices in haemophilia | Economic evaluations | Haematology | Procedure/Method, Results, Statistical methods and analyses | |
| MARE-C & MARE-S | Medical abortion reporting of efficacy: the MARE guidelines. | Clinical trials, Experimental studies, Observational studies | Obstetrics and gynaecology | Whole report |
| Meta-analysis of individual participant data: rationale, conduct, and reporting | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Data, Procedure/Method, Study characteristics (participants etc.) | |
| MOOSE | Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Public health | Whole report |
| Methodical approaches to determine the rate of radial muscle displacement using tensiomyography: A scoping review and new reporting guideline | Clinical trials, Experimental studies, Observational studies | Neurology, Sport and exercise medicine, Surgery | Data, Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) | |
| Methodological challenges when using actigraphy in research | No study design specified | Behavioural medicine, Neurology, Psychiatry | Data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) | |
| Methodological standards for conducting and reporting meta-analyses: Ensuring the replicability of meta-analyses of pharmacist-led medication review | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Pharmaceutical medicine | Data, Statistical methods and analyses | |
| Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review | Clinical trials, Experimental studies, Observational studies | Infectious diseases, Obstetrics and gynaecology | Harms/adverse effects/safety data, Study characteristics (participants etc.) | |
| Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review | Observational studies | Renal medicine | Procedure/Method, Results, Study characteristics (participants etc.) | |
| Methods and Applications of Social Media Monitoring of Mental Health During Disasters: Scoping Review | Observational studies | Psychiatry, Psychology | Data, Ethical issues (consent etc.), Procedure/Method, Statistical methods and analyses | |
| Methods for developing and reporting living evidence synthesis | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report | |
| MICRO | Microbiology Investigation Criteria for Reporting Objectively (MICRO) : a framework for the reporting and interpretation of clinical microbiology data | Clinical trials, Experimental studies, Observational studies | Infectious diseases | Data, Narrative sections (discussion etc.), Procedure/Method, Results |
| Minimal reporting guideline for research involving eye tracking (2023 edition) | Clinical trials, Experimental studies, Observational studies | Behavioural medicine, Neurology, Ophthalmology, Psychology | Data, Intervention (exposure), Procedure/Method | |
| MIBO | Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO) : Platelet -Rich Plasma and Mesenchymal Stem Cells | Clinical trials, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Rheumatology, Sport and exercise medicine, Surgery | Ethical issues (consent etc.), Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) |
| Minimum data elements for research reports on CFS | Observational studies, Qualitative research | Infectious diseases, Neurology | Data | |
| MI-CLAIM | Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist | Artificial intelligence/Machine learning studies | No clinical specialty specified | Data, Results, Study characteristics (participants etc.) |
| Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines | Observational studies | Oncology | Data | |
| Modeling Infectious Diseases in Healthcare Network (MInD-Healthcare) Framework for Describing and Reporting Multidrug-resistant Organism and Healthcare -Associated Infections Agent-based Modeling Methods | Observational studies | Infectious diseases, Public health | Statistical methods and analyses | |
| More medical journals should inform their contributors about three key principles of graph construction | No study design specified | No clinical specialty specified | Figures/Graphs | |
| Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group | Clinical trials, Diagnostic and prognostic studies, Experimental studies, Observational studies | Oncology, Pathology | Whole report | |
| Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls | No study design specified | Public health | Data, Statistical methods and analyses | |
| Murine models of radiation cardiotoxicity: a systematic review and recommendations for future studies | Animal pre-clinical research | Oncology, Radiology | Harms/adverse effects/safety data, Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) | |
| STRIVE | Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration | Clinical trials, Experimental studies, Observational studies | Neurology, Radiology | Images, Terminology/definitions |
| New reporting items and recommendations for randomized trials impacted by COVID- 19 and force majeure events: a targeted approach | Clinical trials, Experimental studies | No clinical specialty specified | Abstract, Harms/adverse effects/safety data, Intervention (exposure), Narrative sections (discussion etc.), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) | |
| STROMA | Overview of methods used in cross-cultural comparisons of menopausal symptoms and their determinants: Guidelines for Strengthening the Reporting of Menopause and Aging (STROMA) studies | Observational studies | Obstetrics and gynaecology | Whole report |
| PRESENT 2020 | PRESENT 2020: Text Expanding on the Checklist for Proper Reporting of Evidence in Sport and Exercise Nutrition Trials | Clinical trials, Experimental studies | Nutrition and dietetics, Sport and exercise medicine | Whole report |
| PRIASE 2021 | PRIASE 2021 guidelines for reporting animal studies in Endodontology: a consensus-based development | Animal pre-clinical research | Dentistry | Whole report |
| PRICE 2020 | PRICE 2020 guidelines for reporting case reports in Endodontics: a consensus-based development | Observational studies | Dentistry | Whole report |
| PRIDASE | PRIDASE 2024 guidelines for reporting diagnostic accuracy studies in endodontics: A consensus-based development | Diagnostic and prognostic studies | Dentistry | Whole report |
| PRIRATE | PRIRATE 2020 guidelines for reporting randomized trials in Endodontics: a consensus-based development | Clinical trials, Experimental studies | Dentistry | Whole report |
| PROBE 2023 | PROBE 2023 guidelines for reporting observational studies in Endodontics: A consensus-based development study | Observational studies | Dentistry | Whole report |
| PaCIR | Pa CIR : A tool to enhance pharmacist patient care intervention reporting | Clinical trials, Experimental studies, Observational studies, Qualitative research, Quality improvement studies | Pharmaceutical medicine | Intervention (exposure) |
| P-URS | Paediatric Ureteroscopy (P-URS) reporting checklist: a new tool to aid studies report the essential items on paediatric ureteroscopy for stone disease | Clinical trials, Experimental studies, Observational studies | Paediatrics, Surgery, Urology | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) |
| Perspective: Guidelines for reporting team-based learning activities in the medical and health sciences education literature | No study design specified | Medical education | Whole report | |
| Point and interval estimates of effect sizes for the case-controls design in neuropsychology: rationale, methods, implementations, and proposed reporting standards | Observational studies | Neurology, Psychology | Statistical methods and analyses | |
| IMPACT-RMD Toolkit | Position Statement on Exercise Dosage in Rheumatic and Musculoskeletal Diseases: The Role of the IMPACT-RMD Toolkit | Clinical trials, Experimental studies | Rheumatology | Intervention (exposure) |
| PRICSSA | Preferred Reporting Items for Complex Sample Survey Analysis (PRICSSA) | Observational studies, Qualitative research | No clinical specialty specified | Data, Statistical methods and analyses |
| PRIO-harms | Preferred Reporting Items for Overviews of systematic reviews including harms checklist: A pilot tool to be used for balanced reporting of benefits and harms | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Harms/adverse effects/safety data, Whole report |
| PRIRES | Preferred Reporting Items for Resistance Exercise Studies (PRIRES) : A Checklist Developed Using an Umbrella Review of Systematic Reviews | Clinical trials, Experimental studies, Study protocols | Sport and exercise medicine | Intervention (exposure) |
| PRIDE-CPG-TM | Preferred Reporting Items for the Development of Evidence-based Clinical Practice Guidelines in Traditional Medicine (PRIDE-CPG-TM) : Explanation and elaboration | Clinical practice guidelines | Complementary and alternative medicine | Whole report |
| PROCESS | Preferred Reporting Of Case Series in Surgery (PROCESS) 2023 guidelines | Observational studies | Surgery | Whole report |
| MAPS | Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement | Economic evaluations | No clinical specialty specified | Whole report |
| Preliminary Minimum Reporting Requirements for In -Vivo Neural Interface Research: I. Implantable Neural Interfaces | Clinical trials, Experimental studies, Observational studies | Neurology | Whole report | |
| Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology | Observational studies | Rheumatology | Whole report | |
| BIBLIO | Preliminary guideline for reporting bibliometric reviews of the biomedical literature (BIBLIO) : a minimum requirements | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Data | |
| Preschool vision screening: what should we be detecting and how should we report it? Uniform guidelines for reporting results of preschool vision screening studies | No study design specified | Ophthalmology, Paediatrics | Data, Results, Study characteristics (participants etc.) | |
| CAIR | Presenting artificial intelligence, deep learning, and machine learning studies to clinicians and healthcare stakeholders: an introductory reference with a guideline and a Clinical AI Research (CAIR) checklist proposal | Artificial intelligence/Machine learning studies | Rheumatology, Sport and exercise medicine | Whole report |
| Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest | No study design specified | No clinical specialty specified | Conflict of interest | |
| PRIME | Proposed Requirements for Cardiovascular Imaging -Related Machine Learning Evaluation (PRIME) : A Checklist: Reviewed by the American College of Cardiology Healthcare Innovation Council | Artificial intelligence/Machine learning studies | Cardiovascular medicine | Data, Procedure/Method, Statistical methods and analyses |
| Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials | Clinical trials, Experimental studies | Pharmaceutical medicine | Conflict of interest, Ethical issues (consent etc.), Statistical methods and analyses | |
| Proposed definitions and criteria for reporting time frame, outcome, and complications for clinical orthopedic studies in veterinary medicine | No study design specified | Surgery | Data, Harms/adverse effects/safety data, Outcomes (variables), Terminology/definitions | |
| Protecting the power of interventions through proper reporting | No study design specified | No clinical specialty specified | Intervention (exposure) | |
| Publication guidelines for human heart rate and heart rate variability studies in psychophysiology -Part 1: Physiological underpinnings and foundations of measurement | Clinical trials, Experimental studies, Observational studies | Cardiovascular medicine, Neurology, Psychology | Data, Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) | |
| Publication of population data for forensic purposes | No study design specified | Genetics | Data | |
| Publication of population data of linearly inherited DNA markers in the International Journal of Legal Medicine | No study design specified | Genetics | Data | |
| RATS | Qualitative research review guidelines – RATS | Qualitative research | No clinical specialty specified | Whole report |
| Qualitative research: standards, challenges, and guidelines | Qualitative research | No clinical specialty specified | Whole report | |
| Quality of methods reporting in animal models of colitis | Animal pre-clinical research | Gastroenterology | Procedure/Method | |
| Quality of pain intensity assessment reporting: ACTTION systematic review and recommendations | Clinical trials, Experimental studies, Observational studies | Anaesthesia, Neurology, Occupational therapy, Pharmaceutical medicine, Psychiatry, Psychology | Intervention (exposure) | |
| Quality of reporting in evaluations of surgical treatment of trigeminal neuralgia: recommendations for future reports | No study design specified | Neurology, Surgery | Abstract, Data, Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.), Terminology/definitions | |
| Quality of standardised patient research reports in the medical education literature: review and recommendations | No study design specified | Medical education | Outcomes (variables), Procedure/Method | |
| Quality of study methods in individual- and group-level HIV intervention research: critical reporting elements | No study design specified | Infectious diseases | Data, Intervention (exposure), Outcomes (variables), Study characteristics (participants etc.) | |
| RAMESES II | RAMESES II reporting standards for realist evaluations | Mixed methods studies, Qualitative research | No clinical specialty specified | Whole report |
| RAMESES: meta-narrative reviews | RAMESES publication standards: meta-narrative reviews | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| RAMESES: realist syntheses | RAMESES publication standards: realist syntheses | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| RECORDS | RECORDS : Improved reporting of Monte Carlo Radiation transport studies: Report of the AAPM Research Committee Task Group 268 | Clinical trials, Diagnostic and prognostic studies, Experimental studies | Radiology | Narrative sections (discussion etc.), Procedure/Method, Results, Statistical methods and analyses, Title |
| REFORMS : Consensus-based Recommendations for Machine-learning-based Science | Artificial intelligence/Machine learning studies | No clinical specialty specified | Data, Procedure/Method, Statistical methods and analyses | |
| REPCAN | REPCAN : Guideline for REporting Population-based CANcer Registry Data | Observational studies | Oncology | Whole report |
| REPORT-PFP | REPORT-PFP : a consensus from the International Patellofemoral Research Network to improve REPORTing of quantitative PatelloFemoral Pain studies | Clinical trials, Experimental studies, Observational studies | Rheumatology, Sport and exercise medicine | Whole report |
| REPORT-SCS | REPORT-SCS : minimum reporting standards for spinal cord stimulation studies in spinal cord injury | Animal pre-clinical research, Clinical trials, Experimental studies, Observational studies | Neurology | Intervention (exposure), Procedure/Method |
| REMARK | REporting recommendations for tumour MARKer prognostic studies (REMARK) | Diagnostic and prognostic studies, Observational studies | Genetics, Oncology | Whole report |
| RIGHTCARE-PR | RIGHTCARE-PR : Reporting guidelines for human rights in child and adolescent psychiatry | No study design specified | Paediatrics, Psychiatry | Whole report |
| RULER | Rasch Reporting Guideline for Rehabilitation Research (RULER) : The RULER Statement | No study design specified | Rehabilitation medicine | Statistical methods and analyses |
| Recommendations and publication guidelines for studies using frequency domain and time-frequency domain analyses of neural time series | No study design specified | Neurology, Psychology | Data, Statistical methods and analyses | |
| Recommendations for Reporting Machine Learning Analyses in Clinical Research | Artificial intelligence/Machine learning studies | No clinical specialty specified | Data, Statistical methods and analyses | |
| Recommendations for biomarker identification and qualification in clinical proteomics | Observational studies | No clinical specialty specified | Biospecimen/bioresource information | |
| Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review | Clinical trials, Experimental studies | Oncology | Data, Ethical issues (consent etc.), Intervention (exposure), Outcomes (variables), Procedure/Method, Research recommendations, Results, Study characteristics (participants etc.) | |
| Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine | Observational studies | Complementary and alternative medicine, Pharmaceutical medicine | Harms/adverse effects/safety data | |
| Recommendations for reporting economic evaluations of haemophilia prophylaxis | Economic evaluations | Haematology | Whole report | |
| Recommendations for reporting morbid events after heart valve surgery | No study design specified | Cardiovascular medicine, Surgery | Data, Harms/adverse effects/safety data, Outcomes (variables) | |
| Recommendations for reporting perioperative transoesophageal echo studies | No study design specified | Anaesthesia, Cardiovascular medicine | Procedure/Method, Results, Study characteristics (participants etc.) | |
| Recommendations for reporting the results of studies of instrument and scale development and testing | Clinical trials, Diagnostic and prognostic studies, Experimental studies, Observational studies, Qualitative research, Reliability and agreement studies | No clinical specialty specified | Whole report | |
| Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature | No study design specified | Cardiovascular medicine, Gastroenterology, Renal medicine, Respiratory medicine, Surgery | Statistical methods and analyses | |
| CoPPS | Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the Co PPS Statement | Clinical trials, Experimental studies | Behavioural medicine, Occupational therapy, Physiotherapy, Psychology, Rehabilitation medicine, Sport and exercise medicine | Intervention (exposure) |
| Recommendations for the improved effectiveness and reporting of telemedicine programs in developing countries: results of a systematic literature review | Experimental studies, Observational studies | Health informatics | Intervention (exposure), Narrative sections (discussion etc.), Outcomes (variables), Procedure/Method | |
| Recommendations for the reporting of foot and ankle models | No study design specified | Rheumatology | Procedure/Method | |
| Recommendations for uniform reporting of data following major trauma–the Utstein style | No study design specified | Emergency medicine | Data, Ethical issues (consent etc.), Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective | Clinical trials, Experimental studies | No clinical specialty specified | Harms/adverse effects/safety data | |
| Recommended guidelines for reporting on emergency medical dispatch when conducting research in emergency medicine: the Utstein style | No study design specified | Emergency medicine | Data, Procedure/Method, Results, Terminology/definitions | |
| Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital ‘Utstein style’ | No study design specified | Cardiovascular medicine, Emergency medicine | Data, Ethical issues (consent etc.), Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) | |
| Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style | No study design specified | Emergency medicine | Data, Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) | |
| Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology | No study design specified | Oncology | Narrative sections (discussion etc.), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.) | |
| Recommended guidelines for uniform reporting of pediatric advanced life support: the pediatric Utstein style | No study design specified | Paediatrics | Whole report | |
| EPIFORGE 2020 | Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines | Observational studies | Infectious diseases | Whole report |
| Refining a checklist for reporting patient populations and service characteristics in hospice and palliative care research | No study design specified | Palliative care | Study characteristics (participants etc.) | |
| CRiSPHe | Refining the CRiSPHe (checklist for reporting research using a simulated patient methodology in Health): a Delphi study | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| Reflexology specific guidance for using the template for the intervention description and replication (TIDieR) : A delphi study | Clinical trials, Experimental studies | Complementary and alternative medicine | Intervention (exposure) | |
| Relevance of CONSORT reporting criteria for research on eHealth interventions | Clinical trials, Experimental studies | Health informatics | Intervention (exposure) | |
| CACTUS | Reporting ChAracteristics of cadaver training and sUrgical studies: The CACTUS guidelines | Observational studies | Pathology, Surgery | Ethical issues (consent etc.), Procedure/Method |
| Reporting Data on Auditory Brainstem Responses (ABR) in Rats: Recommendations Based on Review of Experimental Protocols and Literature | Animal pre-clinical research | Audiovestibular medicine, Neurology | Data, Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) | |
| RESIDE | Reporting Eye-tracking Studies In DEntistry (RESIDE) checklist | Observational studies | Dentistry | Whole report |
| GUIDE-Rehab | Reporting GUideline for Intervention DEscription in Rehabilitation (GUIDE-Rehab) | No study design specified | Rehabilitation medicine | Whole report |
| REPRISE | Reporting Guideline for Priority Setting of Health Research (REPRISE) | No study design specified | No clinical specialty specified | Whole report |
| ClinPK | Reporting Guidelines for Clinical Pharmacokinetic Studies: The Clin PK Statement | Experimental studies | Pharmaceutical medicine | Whole report |
| Reporting Guidelines for Health Care Simulation Research: Extensions to the CONSORT and STROBE Statements | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Whole report | |
| Reporting Guidelines for Whole -Body Vibration Studies in Humans, Animals and Cell Cultures: A Consensus Statement from an International Group of Experts | No study design specified | Physiotherapy, Sport and exercise medicine | Intervention (exposure), Procedure/Method, Study characteristics (participants etc.) | |
| RATE-XR | Reporting Guidelines for the Early -Phase Clinical Evaluation of Applications Using Extended Reality: RATE-XR | No study design specified | No clinical specialty specified | No report section specified |
| Reporting Guidelines for the Use of Expert Judgement in Model -Based Economic Evaluations | Economic evaluations | No clinical specialty specified | Ethical issues (consent etc.), Intervention (exposure), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.), Terminology/definitions | |
| PRECISE | Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations -A Report of a European School of Oncology Task Force | Observational studies | Oncology, Radiology, Urology | Images |
| Reporting Standards for Endovascular Repair of Saccular Intracranial Cerebral Aneurysms | Clinical trials, Experimental studies, Observational studies | Neurology, Radiology, Surgery | Harms/adverse effects/safety data, Images, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies | Observational studies | Oncology, Surgery | Statistical methods and analyses, Whole report | |
| Reporting and presenting information retrieval processes: the need for optimizing common practice in health technology assessment | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Procedure/Method | |
| RedHot | Reporting data on homeopathic treatments (RedHot) : A supplement to CONSORT | Clinical trials, Experimental studies | Complementary and alternative medicine | Data |
| Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR / ACR collaborative recommendations | Clinical trials, Experimental studies | Rheumatology | Data, Outcomes (variables) | |
| REHBaR | Reporting experiments in homeopathic basic research (REHBaR) – a detailed guideline for authors | Clinical trials, Experimental studies, Other | Complementary and alternative medicine | Whole report |
| Reporting format for economic evaluation. Part II : Focus on modelling studies | Economic evaluations | Pharmaceutical medicine | Whole report | |
| Reporting gaps in immunization costing studies: Recommendations for improving the practice | Economic evaluations | Infectious diseases | Whole report | |
| Reporting genetic results in research studies: summary and recommendations of an NHLBI working group | Observational studies | Cardiovascular medicine, Genetics, Haematology, Respiratory medicine | Results | |
| RAGEE | Reporting guidance for violence risk assessment predictive validity studies: the RAGEE Statement | Diagnostic and prognostic studies, Observational studies, Reliability and agreement studies | Behavioural medicine | Whole report |
| CHART | Reporting guideline for Chatbot Health Advice studies: the CHART statement | Artificial intelligence/Machine learning studies | No clinical specialty specified | Whole report |
| PRIOR | Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report |
| DECIDE-AI | Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI | Artificial intelligence/Machine learning studies | No clinical specialty specified | Whole report |
| GAMER | Reporting guideline for the use of Generative Artificial intelligence tools in MEdical Research: the GAMER Statement | Artificial intelligence/Machine learning studies | No clinical specialty specified | Whole report |
| CHAIRS | Reporting guidelines for allergy and immunology survey research | Qualitative research | Allergy, Infectious diseases, Rheumatology | Data, Ethical issues (consent etc.), Intervention (exposure), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) |
| Reporting guidelines for evidence-based practice projects: A Delphi study and publication checklist | Observational studies | No clinical specialty specified | Whole report | |
| STORMS | Reporting guidelines for human microbiome research: the STORMS checklist | Observational studies | No clinical specialty specified | Whole report |
| C.A.R.E. | Reporting guidelines for implementation research on nurturing care interventions designed to promote early childhood development | Clinical trials, Experimental studies, Observational studies, Qualitative research | Obstetrics and gynaecology, Paediatrics | Whole report |
| Reporting guidelines for music-based interventions | Experimental studies, Other | No clinical specialty specified | Intervention (exposure) | |
| PhyCARE | Reporting guidelines for physiotherapy case reports: a consensus-based development (PhyCARE) | No study design specified | Rehabilitation medicine, Sport and exercise medicine | Whole report |
| Reporting guidelines for population pharmacokinetic analyses | Clinical trials, Experimental studies | Pharmaceutical medicine | Whole report | |
| BePRECISE | Reporting guidelines for precision medicine research of clinical relevance: the Be PRECISE checklist | No study design specified | No clinical specialty specified | Whole report |
| SPIRIT-iNeurostim | Reporting guidelines for protocols of randomised controlled trials of implantable neurostimulation devices: the SPIRIT-iNeurostim extension | Clinical trials, Experimental studies, Study protocols | Neurology | Whole report |
| Reporting guidelines for qualitative research: a values-based approach | Qualitative research | No clinical specialty specified | Whole report | |
| CONSORT-iNeurostim | Reporting guidelines for randomised controlled trial reports of implantable neurostimulation devices: the CONSORT-iNeurostim extension | Clinical trials, Experimental studies | Neurology | Whole report |
| Reporting guidelines for tear fluid research | Experimental studies, Observational studies | Ophthalmology | Whole report | |
| PRIO for abstracts | Reporting guidelines on how to write a complete and transparent abstract for overviews of systematic reviews of health care interventions | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Abstract |
| eMOOD | Reporting guidelines on remotely collected electronic mood data in mood disorder (e MOOD)-recommendations | No study design specified | Psychiatry | Data, Statistical methods and analyses, Study characteristics (participants etc.) |
| CHILD-Shoe | Reporting of Children’s Footwear Research (CHILD-SHOE) | No study design specified | Paediatrics | Whole report |
| Reporting of data from out-of-hospital cardiac arrest has to involve emergency medical dispatching – taking the recommendations on reporting OHCA the Utstein style a step further | No study design specified | Emergency medicine | Data | |
| Reporting of interaction | No study design specified | No clinical specialty specified | Statistical methods and analyses | |
| Reporting of perinatal pharmacoepidemiology studies | Observational studies | Obstetrics and gynaecology | Whole report | |
| Reporting outcomes of back pain trials: a modified Delphi study | Clinical trials, Experimental studies | Rheumatology | Outcomes (variables) | |
| Reporting participation in case-control studies | Observational studies | No clinical specialty specified | Outcomes (variables), Study characteristics (participants etc.) | |
| MENTOR | Reporting qualitative Methods in Mental Health Research | Qualitative research | No clinical specialty specified | Whole report |
| Reporting results of latent growth modeling and multilevel modeling analyses: some recommendations for rehabilitation psychology | Observational studies | Psychology, Rehabilitation medicine | Data, Results, Statistical methods and analyses | |
| RAPID | Reporting stAndards for research in PedIatric Dentistry (RAPID) : an expert consensus-based statement | No study design specified | Dentistry | Whole report |
| Reporting standard for describing first responder systems, smartphone alerting systems, and AED networks | No study design specified | Cardiovascular medicine, Emergency medicine | Data, Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Statistical methods and analyses, Study characteristics (participants etc.), Terminology/definitions | |
| Reporting standards for angiographic evaluation and endovascular treatment of cerebral arteriovenous malformations | Clinical trials, Experimental studies, Study protocols | Neurology | Harms/adverse effects/safety data, Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Reporting standards for carotid artery angioplasty and stent placement | Clinical trials, Experimental studies | Radiology, Surgery | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.), Terminology/definitions | |
| Reporting standards for carotid interventions from the Society for Vascular Surgery | No study design specified | Radiology, Surgery | Conflict of interest, Harms/adverse effects/safety data, Images, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Reporting standards for clinical evaluation of new peripheral arterial revascularization devices | No study design specified | Radiology, Surgery | Data, Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Reporting standards for endovascular treatment of pulmonary embolism | Clinical trials, Experimental studies | Radiology, Respiratory medicine, Surgery | Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.), Terminology/definitions | |
| Reporting standards for guideline-based performance measures | Clinical practice guidelines | No clinical specialty specified | No report section specified | |
| Reporting standards for literature searches and report inclusion criteria: making research syntheses more transparent and easy to replicate | No study design specified | No clinical specialty specified | Procedure/Method | |
| Reporting standards for percutaneous interventions in dialysis access | No study design specified | Radiology, Renal medicine, Surgery | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) | |
| Reporting standards for percutaneous thermal ablation of renal cell carcinoma | No study design specified | Oncology, Radiology, Renal medicine, Surgery | Harms/adverse effects/safety data, Images, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Reporting standards for psychological network analyses in cross-sectional data | Observational studies | Psychology | Data, Results, Statistical methods and analyses | |
| STARDdem | Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative. | Diagnostic and prognostic studies, Observational studies | Neurology | Whole report |
| Reporting standards for studies of tailored interventions | Experimental studies, Other | No clinical specialty specified | Intervention (exposure) | |
| Reporting standards for thoracic endovascular aortic repair (TEVAR) | No study design specified | Surgery | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Terminology/definitions | |
| REST | Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST) | Diagnostic and prognostic studies | No clinical specialty specified | Whole report |
| Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0 | Observational studies | No clinical specialty specified | Data, Procedure/Method, Terminology/definitions | |
| Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions | Experimental studies, Other | Rheumatology | Intervention (exposure) | |
| Research reporting standards for endovascular treatment of pelvic venous insufficiency | No study design specified | Obstetrics and gynaecology, Radiology, Surgery | Intervention (exposure), Outcomes (variables), Study characteristics (participants etc.), Terminology/definitions | |
| Research reporting standards for image-guided ablation of bone and soft tissue tumors | No study design specified | Oncology, Radiology | Harms/adverse effects/safety data, Images, Intervention (exposure), Outcomes (variables), Procedure/Method, Results, Study characteristics (participants etc.) | |
| Research reporting standards for percutaneous vertebral augmentation | No study design specified | Oncology, Radiology, Rheumatology, Surgery | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) | |
| Research reporting standards for radioembolization of hepatic malignancies | No study design specified | Gastroenterology, Oncology, Radiology | Harms/adverse effects/safety data, Images, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Revealing the wood and the trees: reporting qualitative research | Qualitative research | No clinical specialty specified | Whole report | |
| Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia | Clinical trials, Experimental studies | Haematology, Oncology | Whole report | |
| RiGoR | RiGoR: reporting guidelines to address common sources of bias in risk model development | Diagnostic and prognostic studies, Observational studies | No clinical specialty specified | Whole report |
| Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting | Observational studies | Cardiovascular medicine, Respiratory medicine | Outcomes (variables), Study characteristics (participants etc.) | |
| RICORS 1.0 | Room Indirect Calorimetry Operating and Reporting Standards (RICORS 1.0): A Guide to Conducting and Reporting Human Whole -Room Calorimeter Studies | Observational studies | Nutrition and dietetics | Data, Procedure/Method, Statistical methods and analyses, Study characteristics (participants etc.) |
| SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee | Diagnostic and prognostic studies | Cardiovascular medicine, Radiology | Images, Intervention (exposure), Procedure/Method, Results, Study characteristics (participants etc.) | |
| SPIRIT-Children and Adolescents | SPIRIT-Children and Adolescents | Clinical trials | No clinical specialty specified | Whole report |
| STARBIV | STARBIV : A standard to report biological variation data studies | No study design specified | No clinical specialty specified | Whole report |
| STARE-HI | STARE-HI – Statement on reporting of evaluation studies in Health Informatics | No study design specified | Health informatics | Whole report |
| STARTER | STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting | Clinical trials, Experimental studies | Infectious diseases, Tropical medicine | Data, Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) |
| STARCARDDS | STAndard Reporting of CAries Detection and Diagnostic Studies (STARCARDDS) | Diagnostic and prognostic studies | Dentistry | Whole report |
| STROBE-EQUITY | STROBE-EQUITY | Observational studies | No clinical specialty specified | Whole report |
| STROBE-GEMA | STROBE-GEMA : a STROBE extension for reporting of geographically explicit ecological momentary assessment studies | Observational studies | Behavioural medicine, Health informatics, Psychology, Public health | Whole report |
| STROBE-metagenomics | STROBE-metagenomics : a STROBE extension statement to guide the reporting of metagenomics studies | Observational studies | No clinical specialty specified | Whole report |
| STRICTOTM | STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM) : Extending the CONSORT statement | Clinical trials, Experimental studies, Observational studies | Complementary and alternative medicine | Intervention (exposure) |
| STROPS | STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline | Clinical trials, Experimental studies, Observational studies | Genetics, Pharmaceutical medicine | Whole report |
| Selection and presentation of imaging figures in the medical literature | No study design specified | No clinical specialty specified | Images | |
| Setting number of decimal places for reporting risk ratios: rule of four | No study design specified | No clinical specialty specified | Statistical methods and analyses | |
| Setting the bar in phase II trials: the use of historical data for determining “go/no go” decision for definitive phase III testing | Clinical trials, Experimental studies | Oncology | Data, Procedure/Method | |
| Setting the standards for reporting ruptured abdominal aortic aneurysm | No study design specified | Surgery | Study characteristics (participants etc.), Terminology/definitions | |
| ROBUST | Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study | No study design specified | No clinical specialty specified | Statistical methods and analyses |
| SAGER | Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use | No study design specified | No clinical specialty specified | Whole report |
| Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data | Observational studies | Dermatology, Infectious diseases | Abstract, Data, Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Statistical methods and analyses, Terminology/definitions | |
| Six practical recommendations for improved implementation outcomes reporting | Clinical trials, Economic evaluations, Experimental studies, Mixed methods studies, Observational studies, Qualitative research, Quality improvement studies | No clinical specialty specified | Whole report | |
| CREMAIs | Smartphone -Delivered Ecological Momentary Interventions Based on Ecological Momentary Assessments to Promote Health Behaviors: Systematic Review and Adapted Checklist for Reporting Ecological Momentary Assessment and Intervention Studies | Clinical trials, Experimental studies, Observational studies | Behavioural medicine | Procedure/Method, Results |
| SAR4Research | Social Accountability Reporting for Research (SAR 4Research): checklist to strengthen reporting on studies on social accountability in the literature | Mixed methods studies, Observational studies, Qualitative research | No clinical specialty specified | Whole report |
| SIFHR | Social Innovation For Health Research (SIFHR) : Development of the SIFHR Checklist | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations | No study design specified | Cardiovascular medicine, Radiology | Images, Procedure/Method, Results, Study characteristics (participants etc.) | |
| RISA | Stakeholder analysis in health innovation planning processes: A systematic scoping review | Qualitative research | No clinical specialty specified | Whole report |
| SESAME | Standard Elements in Studies of Adverse Events and Medical Error: the SESAME statement | Clinical trials, Observational studies | No clinical specialty specified | Whole report, Harms/adverse effects/safety data |
| STROBOD | Standardised reporting of burden of disease studies: the STROBOD statement | Observational studies | Public health | Whole report |
| Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group | Clinical trials, Experimental studies | Oncology, Pathology | Intervention (exposure), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop | No study design specified | Ophthalmology | Data, Outcomes (variables), Results, Terminology/definitions | |
| STREAM-URO | Standardized Reporting of Machine Learning Applications in Urology: The STREAM-URO Framework | Artificial intelligence/Machine learning studies, Diagnostic and prognostic studies | Urology | Whole report |
| Standardized definitions and clinical endpoints in carotid artery and supra-aortic trunk revascularization trials | Clinical trials, Experimental studies | Surgery | Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Standardized outcomes reporting in metabolic and bariatric surgery | Clinical trials, Experimental studies, Observational studies | Gastroenterology, Surgery | Outcomes (variables) | |
| Standardized reporting guidelines for emergency department syncope risk-stratification research | Observational studies | Emergency medicine | Data, Outcomes (variables), Study characteristics (participants etc.), Terminology/definitions | |
| Standardized reporting guidelines for studies evaluating risk stratification of ED patients with potential acute coronary syndromes | No study design specified | Cardiovascular medicine, Emergency medicine | Intervention (exposure), Outcomes (variables), Study characteristics (participants etc.) | |
| Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group | Clinical trials, Experimental studies | Cardiovascular medicine | Data, Harms/adverse effects/safety data, Outcomes (variables) | |
| COGS | Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization | Clinical practice guidelines | No clinical specialty specified | Whole report |
| EPaCIR | Standardized reporting on studies of psychiatric pharmacist interventions | Clinical trials, Experimental studies, Observational studies, Qualitative research | Pharmaceutical medicine, Psychiatry | Intervention (exposure) |
| STREAM | Standards for Rapid Evaluation and Appraisal Methods (STREAM) | No study design specified | No clinical specialty specified | Whole report |
| StaRI | Standards for Reporting Implementation Studies (StaRI) Statement | Clinical trials, Economic evaluations, Experimental studies, Mixed methods studies, Observational studies, Qualitative research, Quality improvement studies | No clinical specialty specified | Whole report |
| SUNDAE | Standards for UNiversal reporting of patient Decision Aid Evaluation studies: the development of SUNDAE Checklist | Clinical trials, Experimental studies, Observational studies, Qualitative research | No clinical specialty specified | Whole report |
| Standards for reporting chronic periodontitis prevalence and severity in epidemiologic studies: Proposed standards from the Joint EU / USA Periodontal Epidemiology Working Group | Observational studies | Dentistry | Procedure/Method, Statistical methods and analyses, Study characteristics (participants etc.), Terminology/definitions | |
| SOS-Prehab | Standards for reporting research methods, interventions, and Outcomes in Surgical Prehabilitation studies | Clinical trials | Rehabilitation medicine, Surgery | Whole report |
| Standards for reporting results of refractive surgery | No study design specified | Ophthalmology, Surgery | Data, Outcomes (variables), Results | |
| START | Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group | Experimental studies, Observational studies | Radiology, Urology | Whole report |
| COMPARE | Statistical Analysis and Reporting of Cardiac Output Method Comparison Studies (COMPARE) Statement | No study design specified | No clinical specialty specified | Whole report |
| Statistics in medicine–reporting of subgroup analyses in clinical trials | Clinical trials, Experimental studies | No clinical specialty specified | Statistical methods and analyses | |
| RANCARE | Strengthening tRansparent reporting of reseArch on uNfinished nursing CARE : The RANCARE guideline | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| GRIPS | Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement | Diagnostic and prognostic studies, Observational studies | Genetics | Whole report |
| STRESS | Strengthening the reporting of empirical simulation studies: Introducing the STRESS guidelines | No study design specified | No clinical specialty specified | Whole report |
| Structural brain development: A review of methodological approaches and best practices | Observational studies | Neurology, Radiology | Intervention (exposure), Procedure/Method, Statistical methods and analyses, Study characteristics (participants etc.) | |
| Suggestions for improving the reporting of clinical research: the role of narrative | Clinical trials, Diagnostic and prognostic studies, Experimental studies, Observational studies | No clinical specialty specified | Narrative sections (discussion etc.) | |
| RTARG | Supporting best practice in reflexive thematic analysis reporting in Palliative Medicine: A review of published research and introduction to the Reflexive Thematic Analysis Reporting Guidelines (RTARG) | Qualitative research | Palliative care | Whole report |
| SWiM | Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Narrative sections (discussion etc.), Procedure/Method, Results |
| MMR-RHS | Systematic Development of Standards for Mixed Methods Reporting in Rehabilitation Health Sciences Research | Mixed methods studies | Occupational therapy, Physiotherapy, Rehabilitation medicine | Whole report |
| SILT | Systematic Review and Meta -Analysis of Outcomes After Operative Treatment of Aberrant Subclavian Artery Pathologies and Suggested Reporting Items | Observational studies | Cardiovascular medicine, Surgery | Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.) |
| Systematic Reviews. CRD ’s guidance for undertaking reviews in health care | Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report | |
| STARE-HI Conference papers | Systematic prioritization of the STARE-HI reporting items. An application to short conference papers on health informatics evaluation | No study design specified | Health informatics | Conference paper/abstract |
| Systematic review to determine best practice reporting guidelines for AFO interventions in studies involving children with cerebral palsy | No study design specified | Neurology, Paediatrics | Intervention (exposure), Study characteristics (participants etc.) | |
| Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically | Animal pre-clinical research, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Whole report | |
| Systems Perspective of Amazon Mechanical Turk for Organizational Research: Review and Recommendations | Experimental studies, Observational studies | Psychology | Data, Procedure/Method, Study characteristics (participants etc.) | |
| TIDieR-C | TIDieR-C | Clinical trials | Paediatrics | Intervention (exposure) |
| TIDieR-PHP | TIDieR-PHP : a reporting guideline for population health and policy interventions | Clinical trials, Experimental studies, Observational studies, Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Intervention (exposure) |
| TIDieR-Telehealth | TIDieR-telehealth : precision in reporting of telehealth interventions used in clinical trials – unique considerations for the Template for the Intervention Description and Replication (TIDieR) checklist | Clinical trials, Experimental studies | No clinical specialty specified | Intervention (exposure) |
| TRIPLE C | TRIPLE C reporting principles for case study evaluations of the role of context in complex interventions | Observational studies | Public health | Whole report |
| Target registration and target positioning errors in computer-assisted neurosurgery: proposal for a standardized reporting of error assessment | No study design specified | Neurology, Surgery | Intervention (exposure), Procedure/Method, Terminology/definitions | |
| Ten simple rules for neuroimaging meta-analysis | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Neurology | Data, Procedure/Method, Statistical methods and analyses | |
| APOSTEL 2.0 | The APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies | Clinical trials, Diagnostic and prognostic studies, Observational studies, Study protocols | Neurology, Ophthalmology | Data, Procedure/Method, Statistical methods and analyses, Terminology/definitions |
| The CONSORT statement checklist in allergen-specific immunotherapy: a GA 2 LEN paper | Clinical trials, Experimental studies | Allergy | Whole report | |
| The Chest Wall Injury Society Recommendations for Reporting Studies of Surgical Stabilization of Rib Fractures | Clinical trials, Experimental studies | Surgery | Intervention (exposure), Outcomes (variables), Statistical methods and analyses, Study characteristics (participants etc.) | |
| DoCTRINE | The Do CTRINE Guidelines: Defined Criteria To Report INnovations in Education | Clinical trials, Experimental studies, Observational studies, Qualitative research | Medical education | Whole report |
| GREENBEAN | The GREENBEAN checklist for reporting studies evaluating the effectiveness of EEG-based biomarkers | Diagnostic and prognostic studies | No clinical specialty specified | Whole report |
| The Hu GENet ™ Hu GE Review Handbook, version 1.0. Guidelines for systematic review and meta-analysis of gene disease association studies | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Genetics | Whole report | |
| IDEAL | The IDEAL Reporting Guidelines: A Delphi Consensus Statement Stage specific recommendations for reporting the evaluation of surgical innovation | Clinical trials, Experimental studies, Observational studies | Surgery | Whole report |
| ICARUS | The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative Course | Clinical trials, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | Anaesthesia, Surgery | Harms/adverse effects/safety data |
| LEADING | The LEADING guideline | Observational studies | Psychiatry | Whole report |
| OHStat | The OHStat Guidelines for Reporting Observational Studies and Clinical Trials in Oral Health Research: Manuscript Checklist | Clinical trials, Experimental studies, Observational studies | Dentistry | Whole report |
| ORION | The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection | Clinical trials, Experimental studies, Observational studies, Other | Infectious diseases | Whole report |
| PICOTS-ComTeC | The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report | Economic evaluations, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews | No clinical specialty specified | Intervention (exposure) |
| RETRIEVE | The RETRIEVE Checklist for Studies Reporting the Elicitation of Stated Preferences for Child Health -Related Quality of Life | Economic evaluations, Qualitative research | Paediatrics | Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) |
| RIPI-f | The RIPI-f (Reporting Integrity of Psychological Interventions delivered face-to-face) checklist was developed to guide reporting of treatment integrity in face-to-face psychological interventions | Clinical trials, Experimental studies, Observational studies | Psychology | Intervention (exposure) |
| RIPL | The Reporting Items for Patent Landscapes statement | Patent landscapes | No clinical specialty specified | Whole report |
| RIMES-SE | The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE) | Mixed methods studies, Observational studies | Pharmaceutical medicine, Public health | Whole report |
| READUS-PV | The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV) : Development and Statement | Observational studies | Pharmaceutical medicine, Public health | Abstract, Whole report |
| RECOvER Checklist | The Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist: A Joint Statement by the ERAS ® and ERAS ® USA Societies | No study design specified | Surgery | Whole report |
| SCARE | The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines | Observational studies | Surgery | Whole report |
| SHARE | The SHARE : SHam Acupuncture REporting guidelines and a checklist in clinical trials | Clinical trials, Experimental studies | Complementary and alternative medicine | Intervention (exposure) |
| The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination | Diagnostic and prognostic studies | No clinical specialty specified | Whole report | |
| STARD-AI | The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence | Artificial intelligence/Machine learning studies, Diagnostic and prognostic studies | No clinical specialty specified | Whole report |
| STROCSS | The STROCSS 2024 guideline: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery | Observational studies | Surgery | Whole report |
| SUPER | The SUPER reporting guideline suggested for reporting of surgical technique | Clinical trials, Experimental studies, Observational studies | Surgery | Intervention (exposure) |
| SCRIBE | The Single -Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement | Experimental studies, Observational studies, Other | Behavioural medicine | Whole report |
| TRIPOD-LLM | The TRIPOD-LLM reporting guideline for studies using large language models | Artificial intelligence/Machine learning studies | No clinical specialty specified | Whole report |
| TARES | The Test Adaptation Reporting Standards (TARES) : reporting test adaptations | No study design specified | Psychology | Whole report |
| CRAI | The adapted Autobiographical interview: A systematic review and proposal for conduct and reporting | Qualitative research | Psychology | Intervention (exposure), Procedure/Method, Statistical methods and analyses |
| The case for structuring the discussion of scientific papers | No study design specified | No clinical specialty specified | Narrative sections (discussion etc.) | |
| The importance of uniform venous terminology in reports on varicose veins | No study design specified | Cardiovascular medicine, Surgery | Terminology/definitions | |
| The lessons of QUANTEC : recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome | No study design specified | Oncology | Data | |
| GRAMMS | The quality of mixed methods studies in health services research | Mixed methods studies | No clinical specialty specified | Data, Procedure/Method, Study characteristics (participants etc.) |
| The standard of reporting of health-related quality of life in clinical cancer trials | Clinical trials, Experimental studies | Oncology | Outcomes (variables) | |
| Too many digits: the presentation of numerical data | No study design specified | No clinical specialty specified | Statistical methods and analyses | |
| TEN-SPIDERS | Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS | Clinical trials, Experimental studies, Observational studies | Cardiovascular medicine | Data, Procedure/Method, Statistical methods and analyses |
| Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria | No study design specified | Gastroenterology, Oncology, Radiology, Surgery | Harms/adverse effects/safety data, Outcomes (variables), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions | |
| Transcription factor HIF 1A: downstream targets, associated pathways, polymorphic hypoxia response element (HRE) sites, and initiative for standardization of reporting in scientific literature | No study design specified | Genetics, Oncology | Data | |
| Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitioners | Clinical trials, Experimental studies | Haematology, Oncology | Procedure/Method, Results | |
| Transparent reporting of data quality in distributed data networks | Observational studies | No clinical specialty specified | Data | |
| TARGET | Transparent reporting of observational studies emulating a target trial: the TARGET Statement | Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| Trial Forge Guidance 4: a guideline for reporting the results of randomised Studies Within A Trial (SWATs) | Clinical trials, Experimental studies | No clinical specialty specified | Whole report | |
| Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke | Clinical trials, Experimental studies | Neurology, Radiology, Surgery | Harms/adverse effects/safety data, Images, Intervention (exposure), Outcomes (variables), Study characteristics (participants etc.), Terminology/definitions | |
| Unique identification of research resources in the biomedical literature: the Resource Identification Initiative (RRID) | No study design specified | No clinical specialty specified | Biospecimen/bioresource information | |
| Update of the stroke therapy academic industry roundtable preclinical recommendations | Animal pre-clinical research | Neurology | Conflict of interest, Outcomes (variables), Procedure/Method | |
| Use of actigraphy for assessment in pediatric sleep research | Observational studies | Paediatrics | Data, Procedure/Method | |
| Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations | Economic evaluations | No clinical specialty specified | Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.) | |
| Using qualitative research to develop an elaboration of the TIDieR checklist for interventions to enhance vaccination communication: short report | Clinical trials, Experimental studies | Infectious diseases | Intervention (exposure) | |
| Using the spinal cord injury common data elements | Clinical trials, Experimental studies | Neurology | Data | |
| Using theory of change to design and evaluate public health interventions: a systematic review | Clinical trials, Experimental studies, Observational studies, Qualitative research | Public health | Procedure/Method | |
| Utstein-style guidelines for uniform reporting of laboratory CPR research | Animal pre-clinical research | Cardiovascular medicine | Whole report | |
| Utstein-style guidelines on uniform reporting of in-hospital cardiopulmonary resuscitation in dogs and cats | Clinical trials, Experimental studies, Observational studies | Emergency medicine | Data, Intervention (exposure), Outcomes (variables), Study characteristics (participants etc.), Terminology/definitions | |
| Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements | Clinical trials, Experimental studies | Rheumatology | Outcomes (variables) | |
| Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data | Clinical trials, Experimental studies, Observational studies | Infectious diseases | Harms/adverse effects/safety data, Terminology/definitions | |
| WIDER | WIDER recommendations for reporting of behaviour change interventions | Clinical trials, Experimental studies | Behavioural medicine | Whole report |
| We don’t know what you did last summer. On the importance of transparent reporting of reaction time data pre-processing | Experimental studies, Observational studies | Behavioural medicine, Psychology | Data, Procedure/Method, Statistical methods and analyses, Study characteristics (participants etc.) | |
| What should be done to tackle ghostwriting in the medical literature? | No study design specified | No clinical specialty specified | Acknowledgements, Ethical issues (consent etc.) | |
| Writing for Publication in Veterinary Medicine. A Practical Guide for Researchers and Clinicians | No study design specified | No clinical specialty specified | Whole report | |
| iCHECK-DH | i CHECK-DH : Guidelines and Checklist for the Reporting on Digital Health Implementations | Clinical trials, Experimental studies, Observational studies | No clinical specialty specified | Whole report |
| STARLITE | “Brimful of STARLITE ”: toward standards for reporting literature searches | No study design specified | No clinical specialty specified | Procedure/Method |